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ABSTRACT 
Cells respond to the presence of damaged DNA by activating an interconnected 
web of signaling pathways that mediate the activities of proteins, which detect, repair, and 
restore DNA structure.  In the presence of double-stranded DNA breaks (DSBs), these 
responses are primarily mediated by the ATM protein kinase.  A related kinase, ATR, 
regulates the responses to dysfunctional DNA replication and is also activated, in an ATM-
dependent manner, when DSBs occur during S-phase.  The activation of ATR in response 
to DSBs is in part achieved by the ability of ATM to interact with TopBP1, an inducer of 
ATR activity.  Additionally, in Xenopus egg extracts, the Mre11-Rad50-Nbs1 (MRN) 
complex is required to bridge ATM and TopBP1 together.  With our current work, we 
show that CtIP, a known MRN-interacting protein, is recruited to DSB-containing 
chromatin and interacts with TopBP1 in a damage-dependent manner.  A region containing 
the first two BRCT repeats of TopBP1 is essential for this interaction.  Furthermore, two 
distinct regions of CtIP participate in mediating the association between CtIP and TopBP1.  
The first region includes two putative ATM/ATR phosphorylation sites that when mutated 
lead to a reduction in binding.  Secondly, binding is diminished when an MRN-binding 
region in the N-terminal region of CtIP is deleted, indicative of the involvement of the 
MRN complex in mediating this interaction.  In addition, the binding between CtIP and 
TopBP1 is diminished in Nbs1-depleted extracts and, reciprocally, the binding of Nbs1 to 
TopBP1 decreases in the absence of CtIP.  This suggests the formation of a complex 
containing CtIP, TopBP1 and the MRN complex.  When CtIP is removed from egg 
extracts, the levels of TopBP1 and Nbs1 in damaged nuclei are reduced, thereby 
compromising the activation of the damage response.  Thus, CtIP interacts with TopBP1 in 
a damage-stimulated, MRN-dependent manner to mediate the activation of ATR in 
response to DSBs.  
The chromatin environment in the vicinity of breaks influences the activation of the 
DNA Damage Response (DDR).  In this report, we explore the involvement of the 
chromatin remodeling ATPase ISWI in the responses to DNA damage.  We find that ISWI 
associates with ATR, ATRIP, and TopBP1 on DNA in the presence of damage.  In 
addition, ISWI is a substrate of both ATM and ATR in vitro.  Furthermore, the activities of 
 vi 
ATM and ATR stimulate an increase in the levels of ISWI on chromatin that contains 
DSBs.  Finally, we assessed the role of ISWI in the activation of multiple damage 
responses in Xenopus egg extracts.  Taken together, our work describes several previously 
uncharacterized features of ISWI with implications in the response to damaged and 
incompletely replicated DNA. 
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CHAPTER I 
 
INTRODUCTION 
 
GENOMIC INSTABILITY AND CANCER 
 
Cancer is a disease in which a group of cells loses the capacity to regulate growth 
and control of cell division.  The tissue generated as a result of uncontrolled growth, 
referred to as neoplasia from the Greek word meaning “new growth,” is likely to originate 
from a single cell, which by genetic misfortune or exposure to carcinogens suffers dynamic 
changes in its genome1.  Initially, these lesions are confined to a few cells within a defined 
location.  Via processes formally analogous to Darwinian evolution—shaped by 
interactions with neighboring cells and factors in the cellular microenvironment—the 
founder neoplastic population acquires a series of traits leading to the progressive 
conversion of the surrounding tissue into a highly malignant derivative, commonly known 
as a tumor, with deleterious effects to cellular and organismal homeostasis2.   
In humans, tumorgenesis is a multistep process that is characterized by the 
manifestation of several acquired traits that fundamentally alter cell physiology.  At the 
turn of the millennium, Hanahan and Weinberg described six functional capabilities 
obtained by normal cells that drive tumor development3.  Three of these hallmarks—self-
sufficiency in growth signals, insensitivity to anti-growth signals, and the evasion of 
apoptosis—are reflective of the uncoupling of the cellular growth program from signals in 
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its environment.  In order for the incipient neoplasias to maintain their large size as a result 
of uncontrolled growth, they develop the ability to sustain the process of growth of new 
blood vessels, or angiogenesis, to supply the growing cancerous tissue with oxygen and 
nutrients.  Furthermore, to fulfill their “tumorgenic agenda,” malignant cells overcome the 
cell-autonomous program to limit replication and develop a limitless replicative potential.  
Finally, as the tumor continues to grow it invades the adjacent tissue and colonizes non-
adjacent tissues or organs in other parts of the body in a process referred to as metastasis.   
The conceptual characterization of cancer has been further expanded by a decade of 
advancements in the understanding of the malignant transformation of cells or oncogenesis.  
The growing list of defining traits now includes the evasion of immune surveillance and a 
number of stress phenotypes including metabolic stress, mitotic stress and DNA damage 
and replication stress4,5.  Additionally, the increased levels of instability at the nucleotide 
and chromosomal levels displayed by most human cancers, which, directly or indirectly, 
lead to the acquisition of these traits, are now regarded as a defined capability conducive to 
cancer development3,6,7.   
Two seminal papers by Bartkova, Gorgoulis and their colleagues8,9 supplied 
evidence that the cellular mechanisms that ensure genomic stability serve as a barrier for 
tumorgenesis.  By visualizing key phosphorylation events indicative of the activation of the 
DNA damage response (DDR), both groups could observe that in samples of precancerous 
lesions from early breast and colon tumors, melanomas, and lung and urinary bladder 
carcinomas, DDR markers accumulated relative to healthy specimens.  Interestingly, in 
samples from more invasive tumors, the DDR indicators were absent.  Furthermore, 
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numerous abnormalities and mutations in the proteins involved in DDR, including the 
tumor suppressor p53, were observed in lesions from more advanced stages of 
tumorgenesis8.  These results are consistent with the observed high frequency of p53 
mutations in most types of human cancers10 and suggest that for the full-blown 
development of cancer, cells must overcome the blockage imposed by the pathways that 
monitor DNA damage and activate checkpoints that delay cell cycle progression.  This 
barrier may be breached by mutation of the “genomic caretakers” involved in DDR11.  
Moreover, when healthy cells in culture are induced to overexpress growth factors or 
proteins with known oncogenic functions to recapitulate the excessive growth characteristic 
of human cancers, the cells display signs of replication stress including prematurely 
terminated DNA replication forks and double-stranded DNA breaks (DSBs), both of which 
lead to subsequent activation of DDR12,13.  These key developments sparked the 
formulation of a model for cancer development where the activation of oncogenes 
stimulates aberrant proliferation accompanied by unscheduled initiation of DNA 
replication.  The excessive amounts of DNA replication lead to replication stress and DNA 
damage, which provoke the activation of checkpoints to impede the progression of 
precancerous lesions into more invasive cancers14.  In summary, these findings place the 
vigilance of genomic stability by DDR at a critical juncture in the transformation of healthy 
cells into malignancy. 
In our estimation, gaining a better understanding of the activation and regulation of 
DDR will be fundamental in the development of novel therapies to contain cancer 
progression.  
  
4 
THE DNA DAMAGE RESPONSE (DDR) 
  
DNA replication is a delicate, spatially and temporally coordinated process where 
the sequential assembly of factors onto DNA ensures that the genome of each cell is 
faithfully replicated once per cell cycle15.  Even within this strict framework, subtle 
mistakes may occur when billions of bases are being copied.  The incidence of errors is 
elevated in specific chromosomal loci that tend to acquire gaps and breaks.  These regions, 
known as common fragile sites, are particularly sensitive to replication stress and are also 
frequently rearranged in tumor cells16,17.  In addition, the highly reactive, oxygen-rich 
intracellular environment contains an abundance of by-products of cellular metabolism, 
such as reactive oxygen species (ROS) and free radicals, which pose a continuous threat to 
the stability of DNA molecules.  Based on studies carried out in bacteria and in human 
cells, it has been estimated that DNA breaks occur anywhere from 0.2 to 50 per human 
genome replication in the absence of any exogenous insult18,19.  Even if the conservative 
estimate is assumed, each one of these lesions may have catastrophic consequences, as they 
may give rise to gross chromosomal rearrangements such as translocations, duplications, 
inversions, and deletions that compromise the stability of the genome20.   
To cope with the consequences of normal cellular metabolism, which are 
continuously exacerbated by the exposure to external insults, cells have evolved 
surveillance mechanisms to monitor the genomic integrity and coordinate repair and cell 
cycle progression when damage is detected21,22.  The response to damage is executed by a 
network of interacting pathways known as the DNA Damage Response (DDR)23.  In the 
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presence of aberrant DNA structures, including nicks, gaps, single-stranded DNA 
(ssDNA), and double-stranded DNA breaks (DSBs), the activities of these pathways 
integrate the control of cell cycle transitions and the regulation of DNA repair mechanisms 
with elements of the ongoing cellular physiology, such as transcription and DNA 
replication24.  The resulting circuitry orchestrates these different functionalities through the 
activity of sensors, transducers, mediators, and effectors that respond to specific types of 
DNA lesions and initiate the corresponding subroutines depending on the nature and 
severity of the damage.  
In eukaryotes, two large phosphoinositide 3-kinase (PI3K)-related kinases (PIKKs) 
function as transducers to relay and amplify the damage signal when the integrity of the 
genome is compromised.  In the presence of double-stranded DNA breaks (DSBs), the 
delay of cell cycle progression and the modulation of repair are mainly coordinated by the 
activity of the protein kinase ATM.  ATM is the protein product of a gene that is defective 
in the autosomal disorder ataxia telangiectasia (A-T)25.  A-T is a multisystem disease 
associated with a multitude of cancer-related abnormalities including clinical and cellular 
radiosensitivity, predisposition to lymphoid tumors, immunodeficiency, and chromosomal 
instability26.  On the other hand, the cellular stress response pathways activated as a 
consequence of the presence of other DNA lesions—gaps, nicks, base adducts, prematurely 
terminated replication structures, and also DSBs—are mediated by the ATM-related 
protein kinase ATR27.  ATR is essential for embryonic development and plays a crucial 
role in stabilizing the genome during DNA replication28,29.  The only known link between 
ATR mutation and disease is a splice mutant of ATR found in a few patients of the rare 
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Seckel syndrome, characterized by intrauterine growth retardation, dwarfism, 
microcephaly, and mental retardation30.  Large-scale proteomic analyses of proteins that 
become phosphorylated in response to DNA damage suggest that the ATM and ATR 
signaling networks are responsible for more than 900 regulated phosphorylation events in 
as many as 700 proteins31,32. The breadth of these responses confirms the central role of 
ATM and ATR at the apex of the signaling pathways of DDR.   
A detailed description of the required sensors, interactions and events leading to the 
activation of these two important regulators of the stress response program will be 
discussed below.  The downstream events carried out by mediator and effector proteins as a 
consequence of DDR activation are beyond the scope of our analysis.  More information on 
the mediators and effectors of DDR can be found in33–38. 
 
THE ACTIVATION OF ATM: MORE THAN 1981 
 
The serine/threonine (S/T) protein kinase ATM is a member of the 
phosphoinositide 3-kinase (PI3K)-related protein kinase (PIKK) family, which also 
includes ATM and Rad3-related protein (ATR), the catalytic subunit of DNA-dependent 
protein kinase (DNA-PKcs), mammalian target of rapamycin (mTOR), suppressor of 
morphogenesis in genitalia (SMG-1), and the transformation/transcription domain-
associated protein (TRRAP)39.  Four conserved domains—the FRAP-ATM-TRRAP (FAT) 
domain40, a kinase domain (KD), the PIKK-regulatory domain (PRD)41, and the FAT-C-
terminal (FATC) domain42—are the defining architectural features of PIKKs.  These 
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proteins display diverse biological activities, but specifically ATM, ATR, and DNA-PKcs 
play important roles in the response to DNA damage43.   
In unstressed cells, ATM exists as a catalitically inactive dimer44.  Upon exposure 
to DNA damage, rapid autophosphorylation of ATM molecules occurs in trans allowing 
the inactive dimers to dissociate into active monomers capable of initiating the cellular 
response to damage.  In humans, the phosphorylation event leading to monomerization 
occurs on the conserved FAT domain at serine 1981 (S1981) and likely permits the 
adjacent kinase domain to be more accessible to substrates44.  Since the elucidation of the 
mechanism of activation by intermolecular autophosphorylation, phospho-S1981 has been 
equated to ATM activation.  The simplistic view of a single event leading to ATM 
activation was swiftly challenged by the characterization of other damage-induced 
autophosphorylation sites on human ATM, S367 and S189345.  Mutation of any of these 
sites, or of the previously characterized S1981, to non-phosphorylatable residues, hindered 
the capacity of stably expressed ATM to rescue the radiosensitivity, genomic instability, 
and checkpoint-signaling characteristic of A-T cells45.  In addition, ATM-deficient mice 
expressing ATM from a bacterial artificial chromosome (BAC) with the equivalent to 
human S1981 mutated to alanine (S1987A) as their sole ATM species, displayed no 
discernible defects in ATM-dependent responses and ATM-S1987A was recruited 
normally to laser-induced DSBs46.  Contrary to the observation in mice, but in agreement 
with the initial model, data from A-T cells complemented with transgene-encoded ATM 
and expressing the eukaryotic endonuclease I-PpoI revealed that only the wild-type, but not 
a kinase dead or S1981A mutant ATM, could bind I-PpoI-induced breaks47.  These 
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observations have been gathered from different experimental systems that have examined 
the localization of ATM at different times after the induction of damage (5 minutes after 
micro-irradiation46 and 24 hours after IPpoI induction47).  To clarify these discrepancies, So 
and colleagues monitored the real-time recruitment of fluorescently-tagged ATM proteins 
to micro-irradiated regions by live cell imaging48.   Using this approach, they observe that, 
even though the initial recruitment is unaffected, the ablation of autophosphorylation at 
S1981 accelerates the dissociation of ATM from DSBs48.  Their data suggest that S1981 
autophosphorylation stabilizes ATM at DSBs and is therefore required for proper DDR 
activation.  
Another facet of ATM activation, for which there is more consensus, is the 
requirement of the MRN complex for the recruitment of ATM to sites of damage, a pre-
requisite for activation48–54.  The MRN complex, composed of Mre11, Rad50, and Nbs1, is 
generally considered as the upstream sensor in the damage response pathways mediated by 
ATM55.  Components of the MRN complex are among the first proteins detected at DSBs 
and their initial recruitment is independent of the activity of ATM47,56,57. The initial clues 
that hinted towards a functional interaction between ATM and the MRN complex came 
from the significant overlap in cancer susceptibility phenotypes associated with diseases 
that arise as a consequence of the deficiency of these proteins.  Mre11 mutations cause A-
T-like disorder (ATLD) and hypomorphic mutations of Nbs1 cause Nijmegen breakage 
syndrome (NBS).  Patients suffering from these maladies exhibit immunodeficiency, 
microcephaly, chromosomal instability, and other symptoms that clinically resemble those 
of A-T49,50.   The close relationship between these proteins was further evidenced by the 
  
9 
observation that cells isolated from NBS and ATLD patients are defective in the activation 
of ATM in response to radiomimetic chemicals51.  Furthermore, experiments carried out in 
vitro with purified components showed that the activity of ATM towards its substrates, 
including p53 and Chk2, a principal effector kinase of DDR, was stimulated in the presence 
of the MRN complex58.   
Detailed analyses of the activities of the MRN complex and its components 
cemented the notion of MRN as a DNA damage sensor.  Mre11 is a DNA binding protein 
with 3'–5' exonuclease and ssDNA endonuclease activities that are stimulated by the 
presence of Rad5059.  The resulting Mre11-Rad50 (MR) complex preferentially binds to 
DNA ends60.  This complex is stabilized on DNA by the presence of Nbs1, which is also 
responsible for the stimulation of several enzymatic activities of the complex, such as DNA 
duplex unwinding and the cleavage of hairpins.  These ATP-dependent processing events 
require Rad50 to bind ATP in order to be executed61.  The ATP binding of Rad50 is 
essential for the stimulation of ATM activity, suggesting that DNA end-processing by 
MRN plays a crucial role in the activation of ATM by the presence of DNA breaks53,54.  
The MRN complex can also support the tethering of DNA ends50.  In Xenopus extracts, this 
DNA tethering function of MRN promotes the formation of a high molecular weight DNA 
damage-signaling complex that contains active ATM.  The formation of this complex 
requires an intact Mre11 C-terminal domain that is deleted in some ATLD patients62.  In 
addition to these processing events, the recruitment of ATM to DSBs is achieved by the 
direct interaction between ATM and Nbs152.  This interaction occurs through a defined 
carboxy-terminal motif that is required for the activity of ATM towards its downstream 
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targets.  The C-terminal ATM binding motif of Nbs1 is conserved among the sensor 
proteins of other PIKKs and reflects a common mechanism for the recruitment and 
activation of PIKKs in response to damage52. 
In summary, the activation of ATM in response to DSBs can be viewed as a two-
step process54.  The first step entails the processing and tethering of loose DNA ends by the 
MRN complex and the subsequent recruitment of inactive ATM dimers to sites of damage.  
In a second step, the autophosphorylation of ATM is stimulated, leading to the generation 
of enzymatically active monomers that transduce the damage signal to a plethora of 
downstream substrates.  Furthermore, the retention of these active ATM monomers on 
damage sites is critical for sustained DDR activity. 
The specific circumstances leading to the autophosphorylation of ATM have yet to 
be clearly defined.  A number of candidates that regulate dimer dissociation have been 
studied, among them, several protein phosphatases63–65.  Stemming from the observation 
that treatment of cells with the protein phosphatase inhibitor okadaic acid (OA) induces 
autophosphorylation of ATM on serine 1981 in the absence of damage, Goodarzi and 
colleagues characterized an interaction between protein phosphatase 2A (PP2A) and ATM 
that is disrupted in the presence of damage63.  Similar effects have been observed when the 
activity of the Wip1 phosphatase is compromised65.  These observations suggest that ATM 
is continuously maintained in an inactive state by the activity of several phosphatases until 
stress is encountered.  In addition to phosphorylation, the increase in the kinase activity of 
ATM in response to damage has been shown to be stimulated by the acetylation of the 
PIKK Regulatory Domain (PRD) of ATM by the Tip60 histone acetyltransferase66.  
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Mutation of the lysine 3016 acetylation site inhibited ATM monomerization and prevented 
the phosphorylation of downstream targets66.   
Since the characterization of the 1981 autophosphorylation, changes in chromatin 
structure have been suspected to mediate dimer dissociation44. In the initial report by 
Bakkenist and Kastan, cells cultured in hypotonic media or treated with agents that relax 
chromatin structure lead to S1981 autophosphorylation in the absence of damage44.  In a 
more recent study, the loss of irradiation-induced acetylation of histone H3 by the 
chromatin binding protein HMGN1 in Hmgn1-/- mice lead to defects in the activation of 
ATM67.  Treatment of murine embryonic fibroblasts (MEFs) derived from Hmgn1-/- mice 
with histone deacetylase inhibitors reversed the decrease in S1987 autophosphorylation 
observed in the absence of HMGN1.  These results add to a growing body of evidence that 
suggests that the loosening of chromatin structure stimulates the activation of ATM and its 
activity towards downstream substrates44,47,67–73.  In light of the leading role played by 
ATM in DDR, we anticipate that much effort will be devoted in the immediate future to 
clearly illuminate the path leading to the activation of ATM.   
 
THE ACTIVATION OF ATR: ATRIP, A TOP AND A TAIL 
  
As detrimental as a single DSB may be, the lesions that trigger the activation of 
ATM are a relatively rare occurrence18,19.  By contrast, ATR is activated during every S-
phase to regulate the firing of replication origins and ensure the stability of replication 
forks74–77.  The requirement of ATR in the maintenance of fork stability is indicated by the 
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increase in chromosomal fragmentation observed in embryos of ATR knockout mice, 
which additionally display severe defects in cellular proliferation, increased incidence of 
tumors, and lethality at early stages of embryogenesis28,29.  Furthermore, ATR deficiency in 
mouse and human cells leads to an increase in the expression of common fragile sites, 
which are specific regions in the genome that have a tendency to exhibit gaps and breaks, 
and are particularly prone to genomic instability75,78. Likewise, elimination of Mec1 
function, the budding yeast homolog of ATR, leads to fork stalling, accumulation of 
replication intermediates and chromosomal fragmentation, specifically in areas where 
replication fork progression is intrinsically slow, termed “replication slow zones.”79  The 
intimate relationship between ATR and the regulation of DNA synthesis is further 
evidenced by the requirement of replication for the activation of ATR-mediated damage 
response pathways that, in turn, inhibit the initiation of DNA replication in the presence of 
damage80–82.    
ATR recognizes a wide array of aberrant DNA structures that trigger its kinase 
activity towards various downstream substrates, principally Chk1, the main effector kinase 
of ATR-mediated responses27,83–85.  In order to undergo activation, ATR must be recruited 
onto sites of damage.   It has long been reasoned that these different types of damage 
possess a common component that is recognized by ATR.  Most data suggest that this 
structure contains single-stranded DNA, which is generally coated by the single-stranded 
DNA (ssDNA) binding protein RPA (Replication Protein A)82,86–88.  Depletion of RPA 
from Xenopus egg extracts compromises the ability of ATR to associate with damaged 
chromatin, thereby jeopardizing its capacity to trigger a checkpoint response82,87.  Similar 
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results have been observed in human and budding yeast systems, suggesting, in conjunction 
with what was observed in Xenopus, that RPA-coated ssDNA (RPA-ssDNA) is the 
common intermediate that serves as a signal to activate the ATR-mediated DDR76,88.  
Subsequently, using cell-free Xenopus nucleoplasmic extracts, Byun and colleagues 
demonstrated that the functional uncoupling of the MCM helicase and the replicative 
polymerase observed in the presence of damage accounts for the generation of unusually 
long stretches of ssDNA89.  In addition to this mechanistic insight, findings from the same 
research group showed that ATR activity, as measured by the phosphorylation of Chk1, 
further increases in the presence of primed ssDNA.  The level of Chk1 phosphorylation 
was also influenced by the amount of ssDNA adjacent to the primer90.  These findings are 
consistent with the previously characterized requirement of RNA primer synthesis by 
primase for the phosphorylation of Chk1 in response to stalled replication forks91.  Taken 
together, these results indicate that the consensus structure that maximally stimulates the 
activity of ATR contains long stretches of RPA-ssDNA adjacent to a double stranded- (ds-
)/ssDNA juncture92.   
ATR is recruited onto the checkpoint-stimulating structure via its stable binding 
partner ATRIP (ATR-intercating protein), which directly binds to RPA52,88,93,94.  ATRIP 
co-localizes with ATR on sites of DNA damage, and its knockdown in human cells using 
small interfering RNA (siRNA), reduces the levels of ATR expression, leading to a loss of 
DDR and cell death93.  The interaction between ATR and ATRIP is mediated by a C-
terminal ATR interaction motif on ATRIP, which physically and functionally resembles the 
ATM-binding motif of Nbs1 described above.  Deletion of the last 32 residues of the 
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human ATRIP, which contain the PIKK-interacting module, abrogates the binding of ATR 
onto sites of damage and inhibits the phosphorylation of Chk1 in response to UV 
irradiation52.  The N-terminus of ATRIP, on the other hand, contains a highly conserved 
acidic patch, the Checkpoint Recruitment Domain (CRD), which interacts with the basic 
cleft of the largest subunit of the RPA heterotrimer, RPA 70.  Consistent with what can be 
observed with human proteins, mutating the CRD of Ddc2, the budding years homolog of 
ATRIP, prevents proper localization of Ddc2 to DNA breaks and sensitizes yeast cells to 
DNA-damaging agents94.  Together, these findings define ATRIP as an obligate subunit of 
ATR, which is indispensable for the recruitment of ATR to RPA-ssDNA.    
Once recruited onto sites of damage, ATRIP additionally stimulates the activity of 
ATR by mediating the interaction between ATR and TopBP141.  Vertebrate TopBP1, along 
with its fission and budding yeast homologs, Cut5 and Dpb11, have been characterized as 
having dual roles in the initiation of DNA replication and the regulation of checkpoint 
responses95,96.  In Xenopus extracts, TopBP1 is required for the assembly of the checkpoint 
signaling machinery at sites of damage.  The notion of TopBP1 as an essential regulator of 
ATR has been further substantiated by findings from our laboratory.  The work of Akiko 
Kumagai describes a region of TopBP1 that specifically associates with ATR and strongly 
stimulates ATR kinase activity97.  In a manner that is dependent on the presence of ATRIP, 
incubation of ATR with the ATR-activating domain (AAD) of TopBP1 leads to a dramatic 
increase in the intrinsic kinase activity of ATR.  Furthermore, ectopic expression of an 
AAD-containing TopBP1 fragment in human cells stimulates the phosphorylation of 
physiological substrates of ATR in the absence of stress97.  Likewise, subsequent work 
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from Toledo and colleagues showed precocious ATR activation by overexpression of the 
TopBP1 AAD98.  In a heterologous experimental setup, a retrovirally expressed AAD of 
human TopBP1 could be selectively induced to localize to the nucleus of mouse cells.  
Induction of nuclear localization triggered ATR activity in the absence of damage98.  In 
fact, continuous stimulation of ATR in this system drove cells into senescence, providing 
additional evidence of the tumor-suppressive potential of DDR98.  Together, these findings 
have described a leading role for TopBP1 to establish its position as a prominent actor in 
the ATR activation stage. 
Within the framework of DDR, ATR is a transducer of the DNA damage signal to a 
host of downstream mediators and effectors.  As is the case with ATM, a sensing complex 
is required to detect damage and enhance the recruitment and retention of ATR on sites of 
damage.  In response to replication stress, this sensor is the Rad9-Hus1-Rad1 (9-1-1) 
complex99,100.  The 9-1-1 complex forms a heterotrimeric ring-shaped molecule that 
structurally resembles the proliferating cell nuclear antigen (PCNA), a sliding clamp that is 
loaded around DNA at sites of ongoing replication to enhance polymerase processivity100.  
During normal DNA replication, loading of PCNA is achieved by the activity of a clamp 
loader, the pentameric Replication Factor C (RFC)15.  In an analogous manner, a damage 
specific clamp loader, Rad17, together with the four smaller RFC subunits, loads the 9-1-1 
complex onto sites of damage independently of ATR101,102.  Both, Rad17 and 9-1-1 display 
increased affinity towards DNA ends adjacent to RPA-ssDNA, underlying the importance 
of this unique structure in damage recognition by sensors103.  The recognition of similar 
structures by ATRIP and Rad17/9-1-1 suggests that, the proximity of these factors, which 
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are independently recruited to lesions, is what stimulates their activity.  Evidence to support 
this model comes from work done in budding yeast, where the induced co-localization of 
Mec1-Ddc2 and 9-1-1 onto DNA is sufficient to trigger the activation of the Chk1 homolog 
Rad53 in the absence of damage104.  In agreement with this proximity model, the budding 
yeast 9-1-1 complex has been reported to directly activate Mec1 in vitro103.   
The proximity-induced direct activation of ATR by 9-1-1 has not been observed in 
any other organism.  Instead, what has been clearly demonstrated in eukaryotes is that, in 
response to stalled replication forks, the 9-1-1 complex activates checkpoint signaling by 
regulating the interaction between ATR and TopBP1105,106.  In Xenopus, the interaction 
between 9-1-1 and TopBP1 is mediated by the first two Brca1 C-terminus (BRCT) repeats 
of TopBP1.  BRCT repeats are phosphopeptide interacting modules common in proteins 
involved in DNA damage and cell cycle repair107.  Other than mediating the interaction 
with 9-1-1, the BRCT I-II region of Xenopus TopBP1 is required to establish the 
interaction between ATR-ATRIP and TopBP1, a prerequisite for Chk1 activation106.  The 
binding of 9-1-1 to the BRCT I-II of TopBP1 occurs via the extensively modified C-
terminal tail of Rad9, which has been previously shown to interact with TopBP1105,108.  
Specifically, the constitutive phosphorylation of the Rad9 C-terminal tail on serine 373 
(S373) in critical for the interaction with TopBP1.  In addition, the activity of Rad17 has 
proven to be instrumental in the establishment of the TopBP1/9-1-1 interaction.  
Immunodepletion of Rad17 from egg extracts compromises the recruitment of 9-1-1 and 
reduced the accumulation TopBP1 on stalled forks thereby affecting Chk1 activation.  
Whereas addition of wild-type Rad17 restored these defects, an ATP-binding deficient 
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mutant of Rad17 could not109.  These recent finding by our laboratory have lead to the 
formulation of a model that summarizes our current understanding of the 9-1-1-mediated 
activation of ATR in response to stalled replication forks109.  Initially, Rad17 loads 9-1-1 
onto DNA, which already contains a basal level of TopBP1 required for the initiation of 
replication.  Subsequently, an increase in the level of TopBP1 on chromatin is stimulated 
by the presence of both Rad17 and 9-1-1.  Finally, the accumulated TopBP1 interacts with 
ATR-ATRIP leading to an increase in the activity of ATR to its downstream substrates.   
 
THE ATM-TO-ATR SWITCH 
  
Many different aberrant DNA structure induce the activity of ATR.  Among them, 
double-stranded DNA breaks (DSBs) are capable of triggering an ATR-mediated response.  
Until recently, how this was achieved remained unknown.  To address this issue, Jazayeri 
and colleagues took advantage of the fact that ionizing radiation (IR) induces the activation 
of both ATM- and ATR-mediated damage responses110.  By monitoring the response to IR 
in A-T and ATR-Seckel cells, they observed that, although the phosphorylation of most 
ATM-specific substrates is compromised in ATM deficient A-T cells, activation of these 
substrates occurs normally in Seckel cells, which display compromised ATR responses.  In 
a similar fashion, ATR-specific substrates are still phosphorylated in A-T cells.  
Conversely, the phosphorylation of Chk1 is defective in both cell types.  In addition to 
ATM, the IR-induced phosphorylation of Chk1 requires the nuclease activity of Mre11 in 
order to process DSBs and generate the ssDNA-RPA needed to activate ATR.  Moreover, 
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the activation of ATR by ATM in response to DSBs is restricted to S and G2 phases of the 
cell cycle and requires the activity of a cyclin-dependent kinase (CDK)110.  This 
requirement of CDK in this process is consistent with the observed requirement of CDK1 
in budding yeast to promote RPA-ssDNA formation and Mec1 activation during S and 
G2111.   
Subsequently, CtIP, which physically and functionally interacts with Mre11, was 
shown to promote ATR activation in response to DSBs by stimulating end resection and 
generation of RPA-ssDNA.  CtIP, which is specifically recruited to DSBs at S and G2 
phases, is also required for efficient repair of breaks by homologous recombination 
(HR)112.  CtIP is the eukaryotic homolog of the budding yeast Sae2 and fission yeast Ctp1 
proteins113.  The abnormal phenotypes of isolated sae2 null mutants—unresected DSBs, 
defects in repair by HR, and damage sensitivity—are almost identical to the ones conferred 
by some rad50 and mre11 mutant alleles.  These observations have prompted Sae2 to be 
considered as the “fourth member” of MRX, the budding yeast MRN complex114.  The 
ability of CtIP to stimulate the resection of DSBs is partly modulated by the 
phosphorylation of two conserved residues by CDK, serine 327 (S327) and threonine 847 
(T847)115.  Mutation of S327 compromises the capacity of CtIP to generate RPA-ssDNA, 
leading to defects in HR, specifically in G2 and M phases.  Conversely, repair by 
microhomology-mediated end joining (MMEJ), a more error-prone homology-independent 
pathway, is not affected in the absence of S327 phosphorylation115.  The phosphorylation 
on S327 is also critically important to mediate the interaction between CtIIP with the tumor 
suppressor protein BRCA1116.  Together, these results lead to the proposal of a model 
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where the CDK-stimulated resection of ends modulated by CtIP promotes a switch from 
repair by the error-prone MMEJ pathway to error-free HR as cells progress through S-
phase.  This transition allows increased fidelity of repair and promotes genomic stability in 
the face of DNA damage112.  In addition, we speculate that the expansion of RPA-ssDNA 
achieved by the activity of CtIP, which is conducive to ATR activation, might represent an 
amplification step in the response to DSBs, which is exclusive to S-phase when DNA is 
more sensitive to insults. 
The activation of ATR in response to stalled forks not only requires the RPA-
ssDNA template for activation, but also the TopBP1 stimulatory activity and the 
localization to sites of damage by a sensor complex.  Interestingly, ATM stimulates the 
interaction between ATR and TopBP1 in the presence of DSBs117.  ATM phosphorylates 
TopBP1 within the AAD on serine 1131 of the Xenopus protein, to enhance the association 
between TopBP1 and ATR-ATRIP.  The DSB-induced activation of ATR is additionally 
enhanced by the interaction between TopBP1 and the MRN complex118.  TopBP1 
specifically interacts with Nbs1 and abrogation of this interaction leads to a decrease in 
Chk1 phosphorylation in egg extracts supplemented with DSB-containing DNA templates.  
The interaction between TopBP1 and Nbs1 requires the same BRCT I-II region required 
for the association of TopBP1 with the 9-1-1 complex118.   
Taken together, these findings suggest that the ATR response to DSBs is mediated 
in a manner very similar to the response to stalled replication forks, but contains an 
additional level of processing that is suggested to be exclusive to stages of the cell cycle 
where homologous sequences are available for repair by HR.  In this view, the MRN 
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complex senses the initial signal, leading to the recruitment of ATM and triggering a 
“normal” ATM-mediated response.  As these ends become processed for repair, RPA-
ssDNA, which is required for repair by HR, is generated 119.  The presence of RPA-ssDNA 
is sensed by proteins involved in ATR activation, namely ATR-ATRIP and TopBP1, 
leading to the stimulation of ATR activity towards its downstream substrates.  It remains to 
be seen if any additional sensors are required to recruit ATR-ATRIP to resected DSBs, or if 
the MRN complex fulfills that role. 
A biphasic DSB response involving ATM and ATR has been human cell extracts 
containing defined DNA structures120.  In this experimental setup, ATM becomes activated 
by strctures composed of a ds/ssDNA junction with either a blunt end or a short single-
stranded overhang (SSO).  As the length of the SSO increases, ATM activation is 
attenuated but ATR activation is potentiated.  In vivo results were consistent with this 
observation, as ATM-mediated phosphorylation events are observed earlier than ATR-
mediated events in cells treated with IR.  In addition, the appearance of indicators of ATR 
activation, in this case Chk1 phosphorylation, can be accelerated by the overexpression of 
CtIP.  The overexpression of CtIP along with Exo1, a nuclease with known roles in DSB 
resection, also lead to a decrease in S1981 phosphorylation of ATM120–123.  These results 
underscore the importance of resection in mediating the ATM to ATR switch.   
In the following chapter we will discuss our most recent findings, which advance 
our understanding of the involvement of CtIP, TopBP1, and the MRN complex in the 
activation of ATR in response to DSBs. 
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CHAPTER II 
 
CTIP INTERACTS WITH TOPBP1 TO MEDIATE THE RESPONSE TO DNA DOUBLE-
STRANDED BREAKS (DSBS) IN XENOPUS EGG EXTRACTS 
 
ABSTRACT 
In the presence of double-stranded DNA breaks (DSBs), TopBP1-dependent 
activation of ATR is achieved by the ability of TopBP1 to interact with ATM.  ATM 
phosphorylates TopBP1 on serine 1131 to enhance the interaction between ATR and 
TopBP1 thereby increasing the kinase activity of ATR towards its downstream substrates.  
In Xenopus egg extracts, the Mre11-Rad50-Nbs1 (MRN) complex is also required to bridge 
ATM and TopBP1 together.  In this report we show that CtIP, which is recruited to DSB-
containing chromatin, interacts with TopBP1 in a damage-dependant manner.  An N-
terminal region containing the first two BRCT repeats of TopBP1 is essential for this 
interaction.  Furthermore, two distinct regions in the N-terminus of CtIP participate in 
mediating the association between CtIP and TopBP1.  The first is a region that includes a 
potential ATM/ATR phosphorylation site on serine 275 (S275).  Secondly, binding is also 
diminished when an MRN-binding region spanning residues 25–48 is deleted, indicative of 
a role for the MRN complex in mediating this interaction.  This was further evidenced by a 
decrease in binding between CtIP and TopBP1 in Nbs1-depleted extracts and a reciprocal 
decrease in the binding of Nbs1 to TopBP1 in the absence of CtIP, suggestive of the 
formation of a complex containing CtIP, TopBP1 and the MRN complex.  When CtIP is 
immunodepleted from egg extracts, the activation of the response to DSBs is compromised 
and the levels of TopBP1 and Nbs1 on damaged nuclei are reduced.  Thus, CtIP interacts 
with TopBP1 in a damage-stimulated, MRN-dependent manner to mediate the activation of 
ATR in response to DSBs.  
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INTRODUCTION 
 
Eukaryotic cells have evolved a series of intricately choreographed processes to 
ensure that their DNA is swiftly repaired if harmed by the continuous assault of metabolic 
byproducts and exogenous insults22.  A failure in repair is usually associated with multiple 
pathological disorders, including cancer7.  Genomic safeguarding is achieved by the 
activation of checkpoints that delay cell cycle progression while damage is being 
repaired35,124.  Members of phosphoinositide 3-kinase (PI3K)-related protein kinase (PIKK) 
family of protein kinases, ATM and ATR, function as the principal regulators of the 
response to damaged DNA25,27,74.  ATM specifically responds to double-stranded DNA 
breaks (DSBs), the most deleterious form of damage14.  Conversely, ATR is activated in 
response to different types of DNA lesions, including DSBs, and has been largely 
characterized as the main apical kinase in the response to stalled replication forks27.   
The activation of ATR is a highly regulated process that is partly modulated by its 
interaction with other proteins.  Among these factors is the ATR-Interacting Protein 
(ATRIP) that is crucial for the checkpoint regulatory functions of ATR88,93.  ATRIP is 
required to establish a critical association between ATR and the BRCA1 C-terminus 
(BRCT) repeat-containing protein, TopBP1, which is essential for the activation of the 
ATR-ATRIP kinase complex41.  In Xenopus egg extracts and in human cells, the 
exogenous introduction of a TopBP1 fragment that interacts with the ATR-ATRIP 
complex, the ATR-Activating Domain (AAD), triggers an increase in the kinase activity of 
ATR towards a number of substrates including Chk1, the main downstream effector kinase 
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of the DNA Replication Checkpoint97.  The activation of ATR-ATRIP by TopBP1 is 
further regulated by differentially specified interactions determined by the nature of the 
initial source of damage106,109,117,118.  In response to DSBs, the TopBP1-mediated activation 
of ATR is achieved through the phosphorylation of TopBP1 by ATM117.  ATM 
phosphorylates TopBP1 on serine 1131 (S1131), a modification that leads to the 
strengthening of the interaction between ATR and TopBP1 thereby enhances the activity of 
ATR.  The activation of ATR in response to DSBs is additionally regulated by the capacity 
of TopBP1 to interact with the Mre11-Rad50-Nbs1 (MRN) complex, specifically with 
Nbs1118.  The MRN complex is one of the first factors to be localized to DSBs and, 
together with ATM, is responsible for the generation of stretches of single-stranded DNA 
(ssDNA) that are subsequently coated by Replication Protein A (RPA)51,110.  The 
production of ssDNA (RPA-ssDNA) is crucial for proper localization of the ATR-ATRIP 
complex to sites of damage and therefore another important determinant of ATR 
activity88,89,110,120. 
Among the agents that along with ATM and the MRN complex are required for the 
formation of the checkpoint-stimulating RPA-ssDNA is CtIP57,112–114,120,125.  CtIP was 
initially identified in yeast two-hybrid screens as an interacting protein of the 
transcriptional co-repressor CtBP (CtBP-Interacting Protein)126,127.  Subsequently, it has 
been described as an ATM substrate that is recruited to DSBs to mediate the activation of 
repair by homologous recombination (HR)112,115,116,128–132.  In fission yeast and in higher 
eukaryotes the recruitment of Ctp1 and CtIP, respectively, to DSBs is partly mediated by 
the activity of the MRN complex57,113,133.  CtIP has been shown to physically interact with 
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all the components of the MRN complex through multiple points of contact and the 
absence of either CtIP or Mre11 decreases the frequency of HR repair to levels similar to 
those achieved by the depletion of Rad51, a critical regulator of the HR pathway112,133,134.  
Likewise, fission yeast cells lacking Ctp1 displayed defects in HR similar to those observed 
in nbs1Δ and mre11Δ mutant strains.  In addition, ctp1Δ strains were more sensitive to 
DNA-damaging agents because of inefficient formation of RPA-ssDNA adjacent to breaks 
113.  Similar results were observed in human cells, where knockdown of CtIP by siRNA 
resulted in a reduction of RPA accumulation in irradiated regions thereby compromising 
the recruitment of ATR to DSBs, abolishing ATR activity112.  
The parallels exhibited by CtIP and TopBP1 in mediating the activation of ATR by 
regulating the formation of RPA-ssDNA in an ATM- and MRN-dependant fashion 
prompted us to explore the possibility of an interaction between these two checkpoint 
proteins.  Using the Xenopus egg extracts we were successful in characterizing a damage-
stimulated interaction between CtIP and TopBP1 that requires the first two BRCT repeats 
of TopBP1.  The adjacent ATM/ATR consensus phosphorylation sites S273/S275 are also 
required for this interaction and it is further stimulated by the presence of Nbs1.  The 
absence of CtIP in egg extracts compromises the activation of ATR in response to DSBs by 
reducing the level of TopBP1 and Nbs1 on damaged chromatin suggesting that CtIP in 
conjunction with TopBP1 and the MRN complex work together to stimulate the activity of 
ATR in response to DSBs. 
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EXPERIMENTAL PROCEDURES 
 
PREPARATION OF EGG EXTRACTS: Xenopus egg extracts were prepared as described in 135.  
To elicit a checkpoint response extracts were treated with 50 µg/ml of annealed 
oligonucleotides poly(dA)70-poly (dT)70 (pA-pT) in the presence of 3 µM tautomycin as 
described in 33.  To prepare extracts containing chromatin, extracts were supplemented with 
3000 demembranated Xenopus sperm nuclei/µl.  Replication blocks were induced by the 
addition of aphidicolin at 50 µg/ml.  Double-stranded DNA breaks were created by the 
addition of either the restriction endonuclease PflMI (final concentration of 1 U/µl) or 
EcoRI (0.5 U/µl). When noted, caffeine was added at a final concentration of 5 mM.  
Nuclear 136 and chromatin fractions 137 were isolated according to previously described 
methods.  For isolation of fractions from extracts containing caffeine, all buffers were 
supplemented with 5 mM caffeine. 
ANTIBODIES: A DNA fragment encoding amino acids 628–856 of Xenopus CtIP was 
generated by PCR and cloned into a pET-His6 expression vector.  The His6-CtIP (628–
856) protein was expressed in Escherichia coli, isolated with nickel agarose, and used for 
production of rabbit antibodies at a commercial facility.  Affinity-purified antibodies 
against Xenopus versions of ATM, ATR, TopBP1, Nbs1, RPA70, Cdc45 and Orc2 were 
described previously 87,97,118,138.  Anti-human Mcm2 (BM28), anti-FLAG and control rabbit 
antibodies (IgG fraction) were purchased from Cell Signaling Technology, Zymed 
Laboratories and Sigma, respectively. 
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PRODUCTION OF 35S-LABELED PROTEINS: 35S-labeled proteins were synthesized in vitro 
using the TnT System (Promega).  For production of 35S-labeled full-length (amino acids 1-
856) and truncated forms of CtIP (amino acids 1–430, 1–359, 1–298 1–247 and 415–856), 
PCR-generated DNA fragments encoding these regions were cloned into pBluescript and 
the resulting plasmids were used as templates in the TnT system.  Mutant versions of the 
proteins were produced using QuikChange Kit (Stratagene).  35S-Chk1 was generated as 
described in 139 
PRODUCTION OF RECOMBINANT PROTEINS: Recombinant, full-length HF-TopBP1 with both 
hemagglutinin and His6 tags at the N-terminal end and a FLAG tag at the C-terminal end 
was produced in baculovirus-infected Sf9 cells.  Full-length wild-type (WT), DI-II and 
BRCT I-II versions of TopBP1 were generated as described in 118. Point mutations were 
produced using the QuikChange Kit (Stratagene). 
PULLDOWNS OF RECOMBINANT TOPBP1 FROM XENOPUS EGG EXTRACTS: Recombinant 
TopBP1 (WT, KKAM, DI-II, BRCT I-II and BRCT I-II-KKAM) (0.5 µg) bound to anti-
FLAG antibody beads was incubated in egg extracts (100 µl) containing 100 µg/ml 
cycloheximide and 3 µM tautomycin in the absence or presence of 50 µg/ml pA-pT.  When 
noted, caffeine was added at a final concentration of 5 mM.  The beads were isolated by 
centrifugation and washed three times in CHAPS buffer (10 mM HEPES-KOH, pH 7.5, 
0.1% CHAPS, 150mM NaCl, 2.5 mM EGTA, 20 mM β-glycerolphosphate and 0.5% NP-
40) and twice with HEPES-buffered saline (HBS) (10 mM HEPES-KOH, pH 7.5, 150mM 
NaCl).  Bound proteins were subjected to SDS-PAGE and immunoblotting.  
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IMMUNOPRECIPITATIONS: For interphase immunoprecipitations, interphase extracts (100 µl) 
were incubated under constant agitation for 45 min at 4ºC with Affiprep-protein A beads 
(Bio-Rad) coated with anti-TopBP1 (3 µg) or control IgG antibodies (3 µg). The beads 
were isolated by centrifugation and washed three times in CHAPS buffer and twice with 
HBS.  Bound proteins were subjected to SDS-PAGE and immunoblotting.  For nuclear 
immunoprecipitates, nuclei isolated from extracts (250 µl) were subsequently lysed by the 
addition of half the volume of the original extract in CHAPS buffer and incubation at 4ºC 
with rotation for 30 min.  Lysates were spun down in fixed rotor centrifuge for 10 min at 
14,000 x g.  An equal volume of 20 mM HEPES-KOH (pH 7.5) was added to supernatant.  
Diluted lysates were incubated with protein A beads coated with anti-TopBP1 (3 µg), anti-
CtIP (3 µg) or control antibodies (3 µg) under constant agitation for 45 min. at 4ºC.  Beads 
were washed 3 times in CHAPS buffer and twice in HBS before addition of 2X-SDS 
sample buffer for SDS-PAGE and immunoblotting analysis. 
IMMUNODEPLETIONS: For immunodepletion of CtIP, interphase extracts (100 µl) were 
incubated at 4ºC for 60 minutes with 25 µg of CtIP antibodies bound to 20 µl of protein A 
beads.  Equal amounts of rabbit IgG antibodies were used as a control.  After incubation, 
beads were recovered by gentle centrifugation and the supernatants were treated for a 
second round of depletion.  Resulting supernatants were then used in the specified 
experiments.  Nbs1 was immunodepleted as described 138. 
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RESULTS 
 
CTIP ASSOCIATES WITH DSB-CONTAINING CHROMATIN IN XENOPUS EGG EXTRACTS 
The Xenopus egg extract system has been a valuable resource for the molecular 
characterization of the pathways that mediate the response to stalled replication forks.  The 
tools generated to study the activation of these checkpoint pathways have recently been 
utilized in the dissection of the response to double-stranded DNA breaks (DSBs)57,117,118.  
In these studies, DSBs were generated by supplementing egg extracts with the restriction 
endonuclease EcoRI.  Treatment of extracts with EcoRI only yielded a modest activation of 
the DNA damage response as gauged by the phosphorylation of Chk1 in comparison to the 
stronger activation caused by the DNA polymerase inhibitor aphidicolin (Figure 1A, 
compare lanes 2 and 3).  To generate a more robust response to DSBs we used the 
endonuclease PflMI.  This enzyme, which produces non-complementary DNA ends and 
provokes a very robust Chk1 response (Figure 1A, lane 4).  Treatment with PflMI also 
caused a dramatic increase in the nuclear accumulation of RPA, while only causing a 
modest increase in the phosphorylation of Chk2 (Figure 1A, lane 8).   
With this system, we set out to characterize the involvement of CtIP in the DSB 
response.  Upon treatment with PflMI a considerable decrease in the mobility of CtIP was 
observed (Figure 1B), similar to the slower-migrating, hyper-phosphorylated form of CtIP 
that arises in response to ionizing radiation (IR) and topoisomerase inhibitors in human 
cells112,128.  Nbs1, a member of the MRN complex involved in the early stages of DNA 
damage sensing and TopBP1, a crucial regulator of the activation of ATR, both displayed 
  
29 
similar changes in mobility in response to PflMI.  In extracts treated with the aphidicolin 
we could observe a modest increase in the accumulation of CtIP in nuclear fractions but no 
discernible change in mobility.  The replication initiation factor Cdc45, on the other hand, 
displayed significant nuclear accumulation in response to replication blocks triggered by 
aphidicolin but no changes upon treatment with PflMI when compared to untreated 
controls.   
To further characterize the behavior of CtIP in the response to DSBs, we examined 
its recruitment to chromatin in response to damage (Figure 1C).  In the absence of damage 
or in the presence of replication blocks, CtIP only marginally loaded onto chromatin.  
Conversely, we could observe a substantial accumulation of CtIP on chromatin treated with 
PflMI.  The chromatin-bound CtIP also displayed the decreased mobility shift seen in 
nuclear fractions.  PflMI treatment also triggered an increase in the recruitment of TopBP1, 
Nbs1 and the ssDNA-binding protein RPA onto damaged chromatin.  Increased binding of 
a plethora of replication and checkpoint factors in response to damage is regulated by ATM 
and ATR.  Inhibition of these kinases with caffeine disrupts checkpoint signaling and thus 
leads to a failure to activate the downstream effector kinase Chk133.  Interestingly, 
however, certain proteins involved in the regulation of Chk1 activation and other 
checkpoint functions are seen to increase dramatically on damaged chromatin in the 
presence of caffeine87.  To assess if CtIP falls within this class of proteins, we looked at the 
DSB-induced chromatin binding of CtIP in the presence of caffeine (Figure 1D).  This was 
indeed the case, as the levels of CtIP on PflMI-treated chromatin are further increased in 
extracts supplemented with caffeine.  In fact, treatment with caffeine alone or along with 
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aphidicolin leads to a subtle increase of CtIP binding onto chromatin, implying a strong 
correlation between the checkpoint functions of ATM and ATR and the chromatin binding 
of CtIP.  Taken together, our results indicate that a modified form of CtIP is loaded onto 
chromatin containing DSBs and that this recruitment is sensitive to the presence of a 
functional checkpoint apparatus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  CtIP associates with DSB-containing chromatin 
(A) Egg extracts containing 35S-Chk1 (lanes 1–4) or 35S-Chk2 (lanes 5–8) and demembranated sperm nuclei 
were incubated with no checkpoint inducer (lanes 1 and 5) or sperm nuclei treated with 50 µg/ml aphidicolin 
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(lanes 2 and 6), 0.5 U/µl of EcoRI (lanes 3 and 7) or 1 U/µl of PflMI (lanes 4 and 8).  Nuclear fractions were 
isolated and analyzed by phosphorimaging and immunoblotting with anti-RPA antibodies. 
(B) Egg extracts lacking (lane 1) or containing sperm nuclei (lanes 2–4) were incubated without checkpoint 
inducer (lane 2), 50 µg/ml aphidicolin (lane 3), or 1 U/µl PflMI (lane 4).  Nuclear fractions were subjected to 
SDS-PAGE and immunoblotted with anti-TopBP1, anti-CtIP, anti-Nbs1, anti-Cdc45, and anti-Mcm2 
antibodies. 
(C) Egg extracts lacking (lane 2) or containing sperm nuclei (lanes 3–5) were incubated without checkpoint 
inducer (lane 3), 50 µg/ml aphidicolin (lane 4), or 1 U/µl PflMI (lane 5).  Chromatin fractions were subjected 
to SDS-PAGE and immunoblotted with anti-TopBP1, anti-CtIP, anti-Nbs1, anti-RPA70, and anti-Mcm2 
antibodies.  One microliter of extract was loaded in lane 1 as a loading control. 
(D) Chromatin fractions were isolated from egg extracts lacking (lane 2) or containing sperm nuclei treated as 
above in (C) (lanes 3–5) or in the presence of 5 mM caffeine (lanes 6–8).  One microliter of extract was 
loaded in lane 1 as a loading control. 
 
 
CTIP INTERACTS WITH TOPBP1 IN XENOPUS EGG EXTRACTS  
Activation of checkpoint signaling in response to DSBs is mainly regulated by the 
activity of ATM.  The initial activation of ATM in turn leads to an increase in ATR activity 
120.  In egg extracts, the transition from the initiating function of ATM to the subsequent 
activation of ATR is in part achieved by the ATM-dependent phosphorylation of TopBP1 
117.  TopBP1 molecules that have been phosphorylated on S1131 interact more strongly 
with ATR.  This interaction is a crucial step in the initiation of ATR signaling in response 
to damage97,117.  In U2OS cells, CtIP has also been shown to be involved in the recruitment 
to sites of irradiation as well as in its activation112.  The involvement of both TopBP1 and 
CtIP in the activation of ATR in response to DSBs prompted us to investigate if these 
proteins displayed any functional interactions in Xenopus egg extracts.  This was indeed the 
case, as TopBP1 immunoprecipitates (IPs) from interphase extracts supplemented with the 
checkpoint-stimulating synthetic oligonucleotides dA70-dT70 (hereafter termed pA-pT) 
contained CtIP (Figure 2A).  This damage-stimulated interaction was also noticeable in IPs 
from nuclear lysates of extracts treated with PflMI (Figure 2B).  We could also observe the 
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reciprocal interaction, as TopBP1 was present in CtIP nuclear IPs, albeit with a reduced 
degree of damage-dependence.    
 
 
 
Figure 2:  CtIP interacts in a regulated manner with TopBP1 in Xenopus egg extracts 
 
(A) Control IgG (lane 1) and anti-TopBP1 immunoprecipitates (IP) from interphase extracts incubated in the 
absence (lane 2) or presence of 50 µg/ml pA-pT (lane 3) were immunoblotted for CtIP. 
(B) Control IgG (lanes 1–2), anti-CtIP (lanes 3–4) and anti-TopBP1 (lanes 5–6) immunoprecipitates (IP) from 
nuclear fractions isolated from interphase extracts supplemented with demembranated sperm nuclei in the 
absence or presence of 1 U/µl of PflMI.  Isolated nuclear fractions were subjected to SDS-PAGE and 
immunoblotted with anti-TopBP1 and anti-CtIP antibodies. 
 
 
THE BRCT I-II REGION OF TOPBP1 IS NECESSARY AND SUFFICIENT FOR ASSOCIATION WITH 
CTIP 
Having determined that CtIP and TopBP1 associate in a checkpoint-induced 
manner, we investigated which region of TopBP1 is responsible for this interaction.  CtIP 
interacts with the breast cancer tumor suppressor BRCA1 through its BRCT domains in a 
highly regulated manner to modulate the response to DSBs and the activation of repair 
pathways throughout the cell cycle115,116,128–131,140,141.  TopBP1 contains eight BRCT 
domains distributed throughout the length of the protein (Figure 3A).  To assess the 
necessity of specific BRCT domains of TopBP1 in mediating the interaction with CtIP we 
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used a series of deletion mutants of recombinant full-length TopBP1 (HF-TopBP1) lacking 
one or more BRCT repeats106,117.  These FLAG-tagged mutants were added to extracts in 
the absence and presence of pA-pT oligomers and subsequently retrieved for analysis (data 
not shown).  Using this approach, we found that the mutant version of TopBP1 lacking its 
first two BRCT repeats (ΔI-II) fails to interact with CtIP (Figure 3B).  The region 
comprising BRCT repeats I-II is also responsible for the association of TopBP1 with the 
Nbs1 subunit of the MRN complex (Mre11-Rad50-Nbs1), also a key regulator of the 
response to DSBs118.  The interaction between TopBP1 and Nbs1 is compromised when the 
phosphate-binding pocket within the first BRCT repeat of TopBP1 is disrupted by mutating 
two adjacent lysines, K154 and K155 to alanine and methionine respectively (designated as 
the KKAM mutant)118.  To determine if the mode of CtIP binding to TopBP1 is similar to 
or mediated by the presence of Nbs1, we incubated HF-TopBP1-KKAM in egg extracts 
and carried out the pull-downs described above.  The KKAM version of TopBP1 displayed 
a decrease in binding to CtIP, as opposed to a full abrogation of the interaction as seen with 
Nbs1 (Figure 3B).   
To characterize further the requirement of the BRCT I-II region for the CtIP-
TopBP1 interaction we utilized a FLAG-tagged fragment of TopBP1 that only contains the 
first two BRCT repeats (HF-BRCT I-II).   This fragment strongly interacted with CtIP in a 
checkpoint-regulated manner (Figure 3C).  As was the case with the full-length protein, the 
binding of CtIP was decreased when the KKAM mutation was introduced into HF-BRCT 
I-II.   
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Figure 3:  The BRCT I-II region of TopBP1 is necessary and sufficient for association with 
CtIP 
 
(A) TopBP1 domain architecture.  Roman numerals denote BRCT domains of TopBP1.  Full-length HF-
TopBP1 (WT) and versions of TopBP1 lacking residues 96–282 (ΔI-II) or 360–1485 (BRCT I-II) produced in 
Sf9 cells.  Location of residues mutated in KKAM mutants is specified in schematic. 
(B) Anti-FLAG antibody beads containing no recombinant protein (lanes 1 and 2) or the indicated versions of 
HF-TopBP1 (lanes 3–8) were incubated in egg extracts in the absence or presence of pA-pT.  Beads were 
retrieved and immunoblotted with anti-CtIP, anti-Nbs1, and anti-FLAG antibodies. 
(C) Anti-FLAG antibody beads containing no recombinant protein (lanes 1 and 2) or wild-type (lanes 3 and 4) 
and KKAM (lanes 5 and 6) versions of HF-TopBP1-BRCT I-II were incubated in egg extracts in the absence 
or presence of pA-pT.  Beads were retrieved and immunoblotted with anti-CtIP, anti-Nbs1, and anti-FLAG 
antibodies. 
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(D) Representative samples of extracts that were left undepleted (lane 1), mock-depleted with control IgG 
antibodies (lane 2), depleted with anti-CtIP antibodies (lane 3), or depleted with anti-Nbs1 antibodies (lane 4).  
Extracts were immunoblotted with anti-CtIP, anti-Nbs1, and anti-RPA antibodies. 
(E) Anti-FLAG antibody beads containing no recombinant protein (lanes 1 and 2) or wild-type HF-TopBP1 
(lanes 3-8) were incubated in the absence or presence of pA-pT in egg extracts that were either mock-depleted 
with control IgG antibodies (lanes 3 and 4), depleted with anti-CtIP antibodies (lane 5 and 6), or depleted with 
anti-Nbs1 antibodies (lanes 7 and 8).  Beads were retrieved and immunoblotted with anti-CtIP, anti-Nbs1, and 
anti-FLAG antibodies.  In the CtIP immunoblot, the band in lanes 3, 5 and 7 represents cross-reacting band, 
not CtIP signal, as it is present even in CtIP-depleted extracts. 
 
 
In order to define more precisely the contribution of Nbs1 in mediating the 
interaction between CtIP and TopBP1 we carried out HF-TopBP1 pull-downs in extracts 
from which we had immunodepleted Nbs1 (Figure 3D).  In the absence of Nbs1, the 
amount of CtIP that interacts with TopBP1 in response to pA-pT is reduced akin to the 
decreased binding observed with KKAM mutants (Figure 3E).  Interestingly, in extracts 
where CtIP had been removed by immunodepletion, the degree to which Nbs1 interacts 
with TopBP1 in response to damage is also reduced.  Taken together, these results indicate 
that the first two BRCT repeats of TopBP1 are required for association with CtIP.  
Additionally, Nbs1 and CtIP reciprocally mediate their association with TopBP1 in 
response to damage, which suggests the existence of a larger complex that would 
minimally be composed of CtIP, TopBP1 and presumably the whole MRN complex. 
 
TWO DISTINCT REGIONS IN THE N-TERMINUS OF CTIP MEDIATE ASSOCIATION WITH TOPBP1 
We next performed a structure-function analysis of CtIP to determine the region 
within CtIP necessary for interacting with TopBP1.  We initiated these studies by 
generating 35S-labeled fragments of the N-terminal (residues 1–430) and C-terminal 
(residues 415–856) halves of CtIP.  The radiolabeled proteins were incubated in egg 
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extracts containing HF-TopBP1.  Upon retrieval of HF-TopBP1 with anti-FLAG antibody 
beads, we could readily observe that in the presence of pA-pT, the N-terminal, but not the 
C-terminal, fragment of CtIP could bind efficiently to beads containing HF-TopBP1 
(Figure 4A).  While this manuscript was in preparation, You and colleagues57 characterized 
a region of Xenopus CtIP spanning residues 479–584, termed the damage-recruitment (DR) 
motif, which is sufficient for recruitment to EcoRI-treated chromatin in egg extracts.  
Based on our studies, this region appears not to be required for the association of CtIP with 
TopBP1.  This is consistent with the fact that we have observed the CtIP-TopBP1 
interaction in interphase extracts that lack chromatin. 
Next, to more precisely define the region required for this interaction, we tested the 
capacity of smaller N-terminal fragments to bind TopBP1 (Supplementary Figure 1A).  
Among the generated fragments, the one containing residues 1–359 maintains the capacity 
to robustly bind TopBP1, whereas the 1–298 fragment is not as efficient in binding while 
still displaying the large decrease in mobility characteristic of the other binding competent 
peptides.  Moreover, binding is further compromised but not completely abolished in a 
smaller 1–247 fragment that also fails to shift in response to pA-pT.  These studies loosely 
define a region between residues 247–359 that is modified in response to pA-pT and is 
involved in the damage-dependent interaction between CtIP and TopBP1 with an 
additional contribution from another region that further strengthens the interaction.   
The first two BRCT repeats of TopBP1 are required for the interaction with CtIP 
(Figure 3).  Previous work has demonstrated that tandem BRCT repeats form a 
phosphopeptide-binding pocket to mediate their interactions107,142.  Therefore, we 
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endeavored to look for potential phosphorylation sites within amino acids 247–359 of CtIP 
that might be involved in the establishment of the association with TopBP1.  This region 
contains a sequence that is homologous to the known CDK phosphorylation site (SPVF) at 
S327 in human CtIP (Supplementary Figure 1B).  Phosphorylation of this residue by CDK 
mediates the functionally important interaction with BRCA1115,116,130.  However, mutation 
of this critical residue to alanine did not affect the capacity of CtIP to bind TopBP1 in egg 
extracts (Figure 4B).  Another candidate residue within this region is the well-conserved 
ATM/ATR phosphorylation consensus sequence (S/T-Q) on serine 275 of the Xenopus 
protein (Supplementary Figure S1C).  Because in the Xenopus protein this site lies directly 
upstream of another SQ site (containing S273), we mutated both serine 273 and 275 to 
alanine within the context of full-length CtIP (to create the CtIP-2AQ mutant) and then 
performed binding assays to measure the contribution of these sites in mediating the 
interaction with TopBP1 (Figure 4C).  The binding of the 2AQ mutant to TopBP1 was 
reduced in comparison with wild-type CtIP (Figure 4C, lane 10). 
The N-terminal region of human CtIP has been shown to be involved in regulating 
the response to DSBs by interacting with components of the MRN complex133.  
Specifically, residues 22–45 of human CtIP mediate the interaction with the MRN complex 
and are required for proper localization of CtIP to sites of damage and activation of the 
G2/M checkpoint in response to γ-irradiation in HeLa cells.  The corresponding residues 
(25–48 in Xenopus), which are highly conserved among higher eukaryotes (Supplementary 
Figure S1D), were deleted from Xenopus CtIP to assess the extent to which this MRN 
binding region is involved in mediating the interaction with TopBP1.  Consistent with the 
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decrease in the strength of the CtIP-TopBP1 interaction in Nbs1-depleted extracts (Figure 
3E), the degree of binding of CtIP(Δ25–48) to TopBP1 was significantly lower that that of 
full-length CtIP (Figure 4C, lane 15).  Moreover, in a mutant version of CtIP lacking the 
MRN-binding domain in combination with the mutated SQ sites, CtIP(Δ25–48-2AQ), we 
could observe an additive effect, with the interaction being compromised further than for 
the Δ25–48 and 2AQ mutations alone (Figure 4C, lane 20).  It is worth noting that the 
interaction was not fully abolished in the combined mutant, raising the possibility of a 
contribution by an additional site or motif in mediating this interaction. 
In all of the pull-down experiments described above, extracts were supplemented 
with the potent phosphatase inhibitor tautomycin to stabilize the checkpoint-stimulated 
phosphorylation events triggered by pA-pT33.  Omission of tautomycin from these 
incubations essentially abolished the interaction between TopBP1 and Nbs1.  On the other 
hand, we could still observe significant, albeit reduced, binding of CtIP to TopBP1 under 
these conditions (Figure 4D, lane 4).  Utilizing this system, we examined the effect of 
caffeine on the Nbs1-independent interaction between TopBP1 and CtIP.  We could readily 
observe that in the absence of tautomycin, the interaction between CtIP and TopBP1 was 
abolished when the activities of ATM and ATR were inhibited by caffeine (Figure 4D, lane 
5). 
 
Figure 4: Two distinct regions in the N-terminus of CtIP mediate association with TopBP1  
 
(A) Anti-FLAG antibody beads containing no recombinant protein (lanes 1, 4, 7 and 10) or wild-type HF-
TopBP1 (lanes 2–3, 5–6, 8–9 and 11–12) were incubated in egg extracts containing 35S-CtIP N-terminal (1–
430) (lanes 1–6) and C-terminal fragments (415–856) (lanes 7–12) in the absence or presence of pA-pT.  The 
beads were retrieved and bound 35S-labeled proteins were detected by SDS-PAGE and phosphorimaging 
(lanes 4–6 and 10–12.  Lanes 1–3 and 7–9 are representative samples of extracts used in pull-downs. 
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(B) Anti-FLAG antibody beads containing no recombinant protein (lanes 1, 4, 7 and 10) or wild-type HF-
TopBP1 (lanes 2–3, 5–6, 8–9, and 11–12) were incubated in egg extracts containing full-length 35S-CtIP wild-
type (WT) (lanes 1–6) and S328A (lanes 7–12) in the absence or presence of pA-pT.  The beads were 
retrieved and bound 35S-labeled proteins were detected by SDS-PAGE and phosphorimaging (lanes 4–6 and 
10–12.  Lanes 1–3 and 7–9 are representative samples of extracts used in pull-downs.  
 
 
 
 
  
40 
(C) Anti-FLAG antibody beads containing no recombinant protein (lanes 3,8,13 and 18) or wild-type HF-
TopBP1 (lanes 1–2, 4–7, 9–12, 14–17 and 19–20) were incubated in egg extracts containing full-length 35S-
CtIP wild-type (WT) (lanes 1–5), 2AQ (lanes 6–10), Δ25-48 (lanes 11–15) and Δ25-48-2AQ (lanes 16–20) in 
the absence or presence of pA-pT.  The beads were retrieved and analyzed for binding as described in (B). 
(D) Anti-FLAG antibody beads containing no recombinant protein (lanes 1 and 2) or wild-type HF-TopBP1 
(lanes 3–8) were incubated in egg extracts in the absence (lanes 3–5) or presence (lanes 6–8) of tautomycin.  
Checkpoint activation was induced by the addition of pA-pT (lanes 4–5, 7–8) and PIKK activity was inhibited 
by supplementing extracts with 5 mM caffeine (lanes 5 and 8).  Beads were retrieved and immunoblotted with 
anti-CtIP, anti-Nbs1, and anti-FLAG antibodies. One microliter of extract was loaded in lane 9 as a loading 
control. 
(E) Summary of the capacity of indicated forms of CtIP to interact with TopBP1.   
 
 
In summary, as represented in Figure 4E, two distinct regions within the N-
terminus of CtIP are required for the interaction with TopBP1.  The first being the region 
that mediates the binding to the MRN complex at residues 25–48 and a second larger 
region from amino acids 247 to 359.  This second area harbors a conserved putative 
ATM/ATR phosphorylation at S275, which when mutated, along with another adjacent SQ 
site, to a non-phosphorylatable residue (2AQ), partially compromises the interaction.  
Combining the 2AQ mutant with a mutant missing the MRN binding region (Δ25–48) 
displayed an additive effect, suggesting that these two events, the association with the 
MRN complex and the phosphorylation by a PIKK, separately mediate the interaction 
between CtIP and TopBP1.  
 
CTIP MEDIATES DAMAGE-DEPENDANT NUCLEAR ACCUMULATION OF TOPBP1 IN RESPONSE 
TO DSBS IN XENOPUS EGG EXTRACTS  
CtIP is required for the recruitment of ATR to laser-induced DSBs in human cells 
112 and to EcoRI-treated chromatin in Xenopus egg extracts57.  As the recruitment of ATR 
to DSBs is a function of TopBP1 activity and in light of the interaction described above we 
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examined how the depletion of CtIP affected loading of TopBP1 onto chromatin in 
response to DSBs.  To assess the effect of the absence of CtIP we generated an antibody 
directed against a C-terminal region of CtIP (amino acids 628–856) and used it to 
successfully immunodeplete CtIP from egg extracts (Figure 5A). 
We proceeded to determine the effect of depleting CtIP on the activation of the 
checkpoint response to DSBs.  First, we examined the effect of PflMI treatment on the 
accumulation of checkpoint factors together with the activation of Chk1 in nuclear fractions 
of CtIP-depleted extracts.  There is ample evidence to support the role of CtIP in DNA end 
resection, which ultimately leads to the accumulation of RPA57,112,113.  Consistent with 
these observations, we could note a decrease in the PflMI-induced nuclear accumulation of 
RPA in CtIP depleted extracts in comparison with mock-depleted extracts (Figure 5B).  
The loss of resection and ssDNA generation likely to be occurring in the absence of CtIP 
also leads to a compromise in the activation of Chk1, along with a mild decrease in the 
levels of ATM and ATR.  Moreover, the levels of TopBP1 were dramatically reduced in 
the absence of CtIP.  Depletion of CtIP removed a small amount of TopBP1 from 
interphase extracts, possibly due to their association (Figure 5A).  However, the decrease in 
nuclear accumulation of TopBP1 in the absence of CtIP is much more pronounced.  
Moreover, in the absence of damage, the nuclear accumulation of TopBP1 in CtIP-depleted 
extracts is only slightly affected. 
To probe further the effects of the absence of CtIP on the accumulation of TopBP1, 
we isolated PflMI-treated chromatin from depleted extracts and examined the chromatin 
binding of TopBP1 and other checkpoint factors.  Consistent with the observations in 
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nuclear fractions, TopBP1 levels were markedly diminished, with only a minimal amount 
of protein associating with DSB-containing chromatin in the absence of CtIP (Figure 5C).  
Consequently, the critical ATM phosphorylation of the ATR-Activating Domain (AAD) of 
TopBP1 on S1131 that is required for proper activation of ATR in response to DSBs was 
severely compromised.  Furthermore, the levels of ATR on damaged chromatin were 
noticeably reduced and a decrease in the chromatin accumulation of RPA was observed.  
Conversely, the levels of ATM, even though reduced in nuclear fractions, did not decrease 
substantially on chromatin in the absence of CtIP.  In contrast to a previous report57, we 
observed that the levels of Nbs1 on chromatin were significantly reduced in CtIP-depleted 
extracts.  The levels of Nbs1 in egg extracts, on the other hand were not reduced, 
discounting the possibility of co-depletion (Figure 5A).  Taken together, our data strongly 
suggest that CtIP is required for the increase in nuclear accumulation and chromatin 
association of TopBP1 and Nbs1 in response to damage, important steps in the activation of 
ATR in response to DSBs.  
 
 
 
 
 
Figure 5:  CtIP mediates damage-dependent nuclear accumulation of TopBP1 in response to 
DSBs in Xenopus egg extracts 
 
(A) Representative samples of extracts that were either left undepleted (lane 1), mock-depleted with control 
IgG antibodies (lane 2), or depleted with anti-CtIP antibodies (lane 3).  Extracts were immunoblotted with 
anti-ATM, anti-ATR, anti-TopBP1, anti-CtIP, anti-Nbs1, and anti-RPA antibodies. 
(B) Egg extracts containing 35S-Chk1 in the absence (lane 1) or presence of sperm nuclei that were either 
mock depleted with control IgG antibodies (lane 2–3) or depleted with anti-CtIP antibodies (lane 4–5) were 
incubated with no checkpoint inducer (lanes 2 and 4) or in the presence of 1 U/µl of PflMI (lanes 3 and 5).  
Nuclear fractions were isolated and subjected to SDS-PAGE and phosphorimaging to detect radiolabeled 
Chk1 and blotted with anti-ATM, anti-ATR, anti-TopBP1, anti-CtIP, and anti-RPA70 antibodies. 
(C) Egg extracts that were either mock-depleted with control IgG antibodies (lane 1–2) or depleted with anti-
CtIP antibodies (lane 3–4) were supplemented with sperm nuclei in the absence or presence of 1 U/µl of 
PflMI.  Chromatin fractions were isolated and subjected to SDS-PAGE and immunoblotted with anti-ATM, 
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anti-ATR, anti-TopBP1, anti-phospho[S-1131]TopBP1, anti-CtIP, anti-Nbs1, anti-RPA70, and anti-Orc2 
antibodies.  ATM is denoted with an arrow, whereas residual ATR signal from previous blotting is marked 
with an asterisk.   
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DISCUSSION 
 
ATR is activated in response to a wide range of DNA structures ranging from DSBs 
and base adducts to the intermediates that arise upon stalling of replication forks.  These 
observations led to the model that these different structures generate a common 
intermediate that triggers the activation of ATR27.  Various lines of evidence have 
suggested that this structure contains RPA-coated single-stranded DNA (RPA-ssDNA)88, 
89,110,120.  A protein that is critical in the generation of RPA-ssDNA, particularly in response 
to DSBs, is CtIP57,112,113.  Another integral component of the activation of ATR is TopBP1 
whose presence, even in the absence of damage, is sufficient to stimulate the kinase activity 
of ATR towards many of its substrates97,98.  In this report, we have explored the possibility 
of an interaction between CtIP and TopBP1, two critical components for ATR activation, in 
Xenopus egg extracts.  We have found that CtIP and TopBP1 interact in a regulated manner 
in response to checkpoint activation by synthetic oligonucleotides (pA-pT) and DSBs 
generated by restriction endonuclease. 
To understand the nature of this interaction, we generated a series of TopBP1 
deletion mutants lacking one or more of its BRCT domains, which have been shown to be 
involved in mediating damage-stimulated interactions with other checkpoint proteins106,118.  
Utilizing this approach, we determined that the region of TopBP1 containing BRCT 
domains I and II is necessary and sufficient to mediate the interaction with CtIP.  These are 
the same domains required for the interaction between TopBP1 and Nbs1.  Further analysis 
revealed that a version of TopBP1 with a mutation in the BRCT I-II region that abolishes 
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the interaction with Nbs1, TopBP1-KKAM, partially compromises the capacity of CtIP to 
bind TopBP1.  Moreover, depletion of Nbs1 from egg extracts also reduced the interaction 
to a similar extent.  It has previously been demonstrated by work from our laboratory that 
the presence of Nbs1 is critical for another key aspect of the function of TopBP1, namely 
its ability to bridge the interaction between ATM and TopBP1.  In the absence of Nbs1, 
TopBP1 cannot interact with ATM thereby hindering the ability of ATR to be activated by 
ATM in response to DSBs118.  With our current work, we have further shown that CtIP 
participates in the establishment of this interaction as indicated by a decrease in the levels 
of Nbs1 in TopBP1 pull downs from CtIP-depleted extracts.   
The MRN complex mediates the recruitment of CtIP to sites of damage to resect 
DSBs and give rise to RPA-ssDNA57,112,113,133.  Recently, Chen and colleagues133 have 
characterized a region in the N-terminus of human CtIP (residues 22–45) that is critical for 
targeting CtIP to DNA breaks.  This region is capable of interacting with the MRN 
complex, although it is not unique since the C-terminus also has the capacity to bind MRN 
components.  Our structure/function analysis of the Xenopus CtIP reveals that the N-
terminal and not the C-terminal region of CtIP is required for the interaction with TopBP1.  
Furthermore, TopBP1 can only pull down roughly half the amount of a full-length CtIP 
mutant lacking the homologous N-terminal region required for MRN binding, CtIP(Δ25–
48), than it would of wild-type CtIP.  This outcome is not surprising in light of the levels of 
CtIP binding to TopBP1 observed in Nbs1 depletions and KKAM pulldowns.  Overall, 
these results indicate that the regulated interaction between TopBP1 and CtIP in response 
to damage is partially but not fully mediated by the presence of the MRN complex, 
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suggesting the formation of a larger damage-stimulated complex that would at least be 
composed of the MRN complex, CtIP, and TopBP1. 
BRCT repeats mainly interact with phosphorylated substrates107,116,142.  
Phosphorylation of CtIP on serine 327 (S327) of the human protein mediates the formation 
of a CtIP-BRCA1 complex that is involved in regulating the delay in cell cycle progression 
and Chk1 activation in irradiated HeLa cells116.  Subsequent work in avian DT40 cells 
further highlights the importance of this phosphorylation event, where complementation of 
CtIP null cells with CtIP-S327A leads to a decrease in the generation of ssDNA and defects 
in homologous recombination (HR)115. We explored the possibility of the corresponding 
Xenopus site might be required for the interaction with TopBP1.  Mutation of serine 328 to 
a non-phosphorylatable alanine (S328A) had no effect on the interaction.  This result is 
consistent with the notion that even though the phosphorylation of S327 in the human and 
chicken CtIP is required for checkpoint activation, this phosphorylation event is not 
induced by DNA damage116 and the TopBP1-CtIP interaction only occurs in the presence 
of damage. 
To further explore the events that are required for the interaction between TopBP1 
and CtIP we looked at other potential phosphorylation sites within the region that was 
determined to be involved in the interaction (residues 247–359).  Since the interaction 
occurs in response to damage, we turned our attention to potential ATM/ATR sites. A 
couple of S/T-Q sites in CtIP have been demonstrated to be phosphorylation sites for 
ATM128.  Both of these sites lie in the C-terminal region of CtIP, which is not required for 
the TopBP1 interaction.  Sequence alignments with other vertebrate homologs pointed 
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towards two directly adjacent ATM/ATR consensus SQ sites within the 247–359 region, 
the second of which, S275, is highly conserved.  When both of these serines were mutated 
to alanine within full-length CtIP, the binding of the resulting 2AQ mutant to TopBP1 was 
lower relative to the wild-type protein.  Binding was further reduced when these mutations 
were combined with a deletion (Δ25–48) that affects binding to MRN.  In addition, under 
conditions where TopBP1 does not interact with Nbs1, the interaction between TopBP1 
and CtIP is sensitive to caffeine.  When viewed together, the additive effect of the 
combination mutant (CtIP[Δ25–48-2AQ]) and the caffeine sensitivity in the absence of the 
TopBP1-Nbs1 interaction, present a picture where the presence of the MRN complex and 
the checkpoint-stimulated activity of PIKKs comprise two separate modes in which the 
interaction between CtIP and TopBP1 is regulated.   
As mentioned above, CtIP also interacts with MRN through its C-terminal 
domain115.  It is likely that our combination mutants, made in the context of the full-length 
protein, still interact with MRN through the C-terminal region.  These issues will likely be 
clarified by performing pull-down experiments with a recombinant CtIP containing the 
different mutant combinations.  We devoted a lot of time and resources to obtain a 
functional CtIP protein that could be used for this purpose and were unsuccessful in doing 
so.  Current efforts are underway to resolve this issue. 
While this manuscript was in preparation, You and colleagues57 published an article 
characterizing Xenopus CtIP.  Consistent with their results, we observed that a highly 
modified form of CtIP binds to chromatin containing DSBs in egg extracts.  In addition, in 
the presence of replication blocks even though nuclear accumulation of CtIP is evident, 
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mobility is not as severely affected and it did not bind to chromatin.  Interestingly, we 
observed that when caffeine was added to inhibit the activity of ATM and ATR the levels 
of CtIP on chromatin increased even in the absence of damage or when replication is 
blocked.  Furthermore, a massive accumulation was observed when caffeine was added in 
combination with PflMI, mirroring the behavior displayed by other checkpoint factors, 
including TopBP1 and RPA.  These data strongly suggest that CtIP plays a key role in the 
response to DSBs in egg extracts.   
Consistent with what has been observed in mammalian cells112, the activation of 
Chk1 in response to DSBs is defective in the absence of CtIP.  Also, as You et al.57 
demonstrated with EcoRI treatment, the nuclear and chromatin levels of RPA substantially 
decreased in response to PflMI in ΔCtIP extracts.  Likewise, the levels of ATR are reduced 
but not those of ATM.  These observations are concordant with the model presented by 
Shiotani and Zou120 of the involvement of CtIP in the biphasic response to DSBs.  Using 
human cell extracts containing defined DNA structures, they could observe ATM 
activation in the presence of structures with double-stranded ends and short single-stranded 
overhangs (SSOs).  As the length of the overhangs increases or when linearized plasmids 
incubated with nucleases are used as templates, the activity of ATM is reduced whereas the 
activity of ATR increases.  In HeLa cells treated with ionizing radiation (IR) this ATM to 
ATR switch, gauged by Chk1 and Chk2 phosphorylation, was enhanced by the 
overexpression of CtIP and Exo1, an alternative nuclease with known roles in DSB 
resection121–123.  When CtIP and Exo1 were co-expressed the activity of ATM is reduced 
and the level of Chk1 phosphorylation increases at earlier time points suggesting that the 
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switch from ATM to ATR signaling is stimulated by the progressive resection of ends by 
nucleases, which include CtIP. 
Our work adds a key mechanistic insight into the impact of the lack of resection by 
CtIP in the transition from ATM to ATR signaling.  In the absence of CtIP, the amount of 
TopBP1 in the nucleus and on chromatin is drastically reduced.  Concomitantly, 
phosphorylation of S1131 of TopBP1 by ATM is abrogated.  Furthermore, the nuclear 
(data not shown) and chromatin levels of Nbs1 were significantly reduced, in contrast to 
what was reported by You et al.57.  The levels of Nbs1 in egg extracts on the other hand 
were not significantly reduced by the depletion of CtIP (Figure 5A).  It is worth noting that 
PflMI triggers a stronger checkpoint response than EcoRI and the nuclear and chromatin 
accumulation of checkpoint proteins is greater with PflMI (Figure 1A and our unpublished 
data).  The robust accumulation of proteins makes variations in amount more noticeable by 
amplifying even subtle differences.  
In summary, we have described a damage-stimulated interaction between CtIP and 
TopBP1.  Phosphorylation of CtIP on S273/S275, by what is likely to be ATM, partly 
mediates this interaction and it is further enhanced by presence of the MRN complex.  In 
the absence of CtIP the recruitment of both TopBP1 and Nbs1 to damaged chromatin is 
reduced thereby compromising the checkpoint response to DSBs.  These observations 
strongly suggest that CtIP, TopBP1 and the MRN complex collaborate to incite the 
transition from the initial ATM response to the subsequent ATR activity in response to 
DSBs. 
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Supplementary Figure 1:  Sequence conservation of CtIP regions required for binding 
TopBP1 
 
(A) Anti-FLAG antibody beads containing no recombinant protein (lanes 1, 4, 7, 10, 13 and 16) or wild-type 
HF-TopBP1 (lanes 2–3, 5–6, 8–9, 11–12, 14–15 and 17–18) were incubated in egg extracts containing 35S-
CtIP N-terminal fragments 1–359 (lanes 1–6), 1–298 (lanes 7–12) and 1–247 (lanes 13–18) in the absence or 
presence of pA-pT.  The beads were retrieved and bound 35S-labeled proteins were detected by SDS-PAGE 
and phosphorimaging (lanes 4–6, 10–12 and 16–18). Lanes 1–3, 7–9 and 13–15 are representative samples of 
extracts used in pull downs.  Results for each fragment were obtained from separate experiments. 
(B) Sequence alignment of Xenopus, human, and chicken CDK phosphorylation site.  
(C) Sequence alignment of Xenopus, human, and chicken CtIP region around the putative ATM/ATR site 
necessary for binding to TopBP1. 
(D) Sequence alignment of Xenopus, human and chicken Nbs1 binding domain of CtIP (as described in 133) 
necessary for binding to TopBP1.   
 
  
52 
 
CHAPTER III 
 
A ROLE FOR THE CHROMATIN REMODELING ATPASE ISWI IN THE DNA 
DAMAGE RESPONSE (DDR) OF XENOPUS EGG EXTRACTS 
 
ABSTRACT 
The study of the structural requirements for the activation of the DNA Damage 
Response (DDR) has largely focused on the topology directly adjacent to sites of damage.  
Recently, more attention has been placed upon the role of the global chromatin 
environment in mediating these processes.  In this chaper, we explore the involvement of 
the chromatin remodeling ATPase ISWI in the response to damaged DNA in Xenopus egg 
extracts.  We find that ISWI associates with ATR, ATRIP, and TopBP1 on DNA in 
response to DNA damage.  Furthermore, ISWI is phosphorylayted by ATR and ATM on a 
conserved residue, which is adjacent to a domain that is critical for the binding of ISWI 
onto chromatin.  Additionally, the activities of ATM and ATR stimulate an increase in the 
levels of ISWI on chromatin that contains double-stranded DNA breaks (DSBs).  
Furthermore, we assess the role of ISWI in the activation of the responses to DSBs and 
replication blocks in Xenopus egg extracts.  Taken together, our work describes several 
previously uncharacterized features of ISWI with implications in the response to damaged 
and incompletely replicated DNA. 
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INTRODUCTION 
 
The maintenance of the integrity DNA molecules is of paramount importance to 
achieve cellular homeostasis.  Eukaryotic cells handle the continuous onslaught of intra- 
and extracellular insults by multiple means.  One of the first layers of defense that a cell 
employs to shield its genetic material is by packaging DNA around globular protein 
complexes called histones.  The resulting array of DNA molecules spooled around histones 
is further compacted to generate a larger insulating structure called chromatin.  Even in this 
compact conformation DNA molecules are still at risk of being broken or mutated.  In 
cases where damage does occur, cells respond through the activation of a network of signal 
transduction cascades called checkpoints that modulate the control of cell cycle transitions, 
DNA replication and DNA repair21.   
Two large phosphoinositide 3-kinase (PI3K)-related protein kinase (PIKKs) sit at 
the top of these damage-signaling pathways to sense the presence of damage and transduce 
the signal to a plethora of downstream targets35,124.  ATM, the protein product of a gene 
that is defective in the rare autosomal disorder ataxia telangiectasia (A-T) (reviewed in 25) 
mediates the response to double-stranded DNA breaks (DSBs).  DSBs occur naturally as 
V(D)J and meiotic recombination intermediates but increase in frequency by exposure to 
mutagens, at eroded telomeres or in conditions that challenge replication and lead to fork 
collapse.  Failure to repair DSBs in a timely manner may contribute to the genomic 
instability that characterizes the majority of human cancers7,14.   
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A second PIKK and close relative of the ATM kinase, ATR responds to multiple 
types of damage.  These lesions, including DSBs, base adducts and structures that arise 
when replication forks stall, are processed to form a common intermediate that leads to 
ATR activation27.  A growing body of evidence defines this ATR-activating structure as 
long stretches of single-stranded DNA (ssDNA) coated by Replication Protein A (RPA) 
(RPA-ssDNA) adjacent to a juncture between single-stranded and double-stranded 
DNA88,89,110,120.  The initial damage structures are sensed and subsequently processed by 
the activity of multiple nucleases to generate the template for activation112–114,121,123.  RPA 
binds ssDNA and the resulting ssDNA-RPA is recognized by the ATR-Interacting Protein 
(ATRIP)88,93.  Furthermore, ATRIP mediates the association between ATR and TopBP141.  
TopBP1 is a BRCA1 C-terminus (BRCT) repeat containing protein that interacts with ATR 
and leads to an increase in its kinase activity97.  In vitro studies in Xenopus egg extracts and 
human and mice tissue culture cells showed that even in the absence of damage 
overexpression of the key regulatory domain of TopBP1, which mediates the association to 
ATR, the ATR Activating Domain (AAD), leads of an increase in ATR activity97,98.  Once 
activated by TopBP1 ATR can then phosphorylate its downstream substrates that include 
replication and repair proteins as well as the effector serine/threonine kinase Chk1 
(reviewed in 27). 
The activation of ATR illustrates that a defined DNA template is required for the 
full manifestation of the checkpoint response.  In the case of ATM, as observed by 
supplementing Xenopus egg extracts with linear DNA fragments, a minimum of 200 base 
pairs (bp) flanking a DSB is required for proper activation143.  This length roughly 
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coincides with the amount of DNA wrapped around a single nucleosome, suggesting that 
the displacement of histones from the vicinity of damage sites may play a role in regulating 
ATM activity.  Consistent with these findings, human cells that are cultured in hypotonic 
conditions or treated with drugs that lead to chromatin relaxation display an increase in the 
critical autophosphorylation of ATM on serine 1981 even in the absence of damage44.  
Furthermore, murine embryonic stem cells with reduced amounts of linker histone H1, 
which is one of the main factors involved in high-order chromatin compaction, display 
enhanced checkpoint signaling in response to ionizing radiation71.  This effect could also be 
reproduced by treating wild-type cells with histone deacetylase inhibitors implying that an 
open chromatin conformation amplifies the response to DNA damage. From these and 
other reports67,70,144–150, a picture is beginning to emerge in which chromatin acts as a 
selective barrier for the activation and amplification of the checkpoint, which highlights the 
importance of chromatin structure in the DNA Damage Response (DDR). 
In this study, we have characterized a damage-dependent interaction between ATR 
and the ATP-dependent nucleosome remodeling factor ISWI.  This highly conserved 
protein, found in organisms ranging from yeast to mammals, is the primary "motor" of a 
number of chromatin remodeling complexes involved in mobilizing nucleosomes to make 
the chromatin template fluid and allow the appropriate regulation of transcription, DNA 
replication, and chromosome segregation151,152.  The initial characterization of this protein 
in Xenopus revealed that it very tightly associates with chromatin in a cell cycle-regulated 
manner and is required to maintain periodic nucleosomal arrays153,154.  We have 
accumulated some evidence to suggest that the binding of ISWI onto chromatin is 
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enhanced in the presence of DNA breaks in a manner that depends on the activity of ATM 
and ATR.  The absence of ISWI from egg extracts compromises the response to different 
types of DNA damage in conjunction to delaying cell cycle progression, DNA replication 
and displaying the characteristic disruption of nucleosomal spacing.  Taken together our 
results suggest that ISWI actively plays a role in the response to DNA damage in Xenopus 
egg extracts. 
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EXPERIMENTAL PROCEDURES 
 
PREPARATION OF EGG EXTRACTS: Xenopus egg extracts were prepared as described in 135.  
Interphase extracts were supplemented with 3,000 demembranated Xenopus sperm 
nuclei/µl.  Aphidicolin was used at 50 µg/ml.  EcoRI used at a final concentration of 0.5U/ 
µl and PflMI used at 1U/µl.  Sperm chromatin was UV irradiated with 300 J/m2 unless 
otherwise noted.  Caffeine was added at a final concentration of 5 mM and wortmannin 
used at 100 µM.  Nuclear fractions 138 and chromatin fractions 137 were isolated according 
to previously described protocols.  One-step chromatin isolations were carried out 
according to 87.  
PRODUCTION OF RECOMBINANT ISWI IN INSECT CELLS: Full-length ISWI clone 
(MGC:79877 IMAGE:6317687) was obtained from Open Biosystems.  A PCR-generated 
version with NcoI and SpeI sites was cloned into pFastBac with downstream FLAG and 
polyhistidine tags (HF-ISWI).  Recombinant baculoviruses were produced using the Bac-
to-Bac system (Invitrogen).  Sf9 insect cells were infected with recombinant baculovirus 
for protein expression following the manufacturer's specifications.  Proteins used in pull-
down experiments were purified with nickel agarose.  Proteins used to assess chromatin 
binding and as substrates in kinase assays were purified with Anti-FLAG M2 beads 
(Sigma).  Mutant versions of the protein were produced using QuikChange Kit 
(Stratagene).    
PRODUCTION OF RECOMBINANT ISWI FRAGMENTS IN BACTERIA: PCR-generated ISWI 
fragments spanning regions corresponding to amino acids 473–533, 692–752 and 803–863 
  
58 
were amplified and cloned into pGEX-4T3 vector using BamHI and XhoI sites.  Constructs 
were expressed in Escherichia coli and purified using glutathione beads.  Eluted proteins 
were used as substrates in ATR kinase assays described below.  Mutant versions of the 
protein were produced using QuikChange Kit (Stratagene).    
ATR KINASE ASSAY: FLAG-ATRIP-Δ222 was incubated in egg extracts following the 
specifications detailed in 97. ATR-ATRIP complexes were recovered and subsequently 
used for kinase assays following the protocol detailed in the publication mentioned above. 
ANTIBODIES: ISWI cDNA encoding amino acids 671–1019 of ISWI clone reported by 154 
(corresponding to 649–1046 of clone used 155) in a pRSetB expression vector with a 
downstream polyhistidine coding sequence was expressed in Escherichia coli, isolated with 
nickel agarose beads and used for production of rabbit antibodies at a commercial facility.  
The pRsetB-ISWI (671–1019) construct was a kind gift from Dr. Marcel Méchali.  Purified 
antigen was also used as a substrate in ATR kinase assays described above. Affinity-
purified antibodies against Xenopus versions of ATM, ATR, TopBP1, Nbs1, RPA70, 
Chk2, and Orc2 were described previously 84, 87, 97, 118, 138.  
IMMUNODEPLETION OF ISWI: For immunodepletion of ISWI, interphase extracts (100 µl) 
were incubated at 4ºC for 60 min with 30 µg of ISWI antibodies bound to 20 µl of 
Affiprep-protein A beads (Bio-Rad).  Equal amounts of rabbit IgG antibodies were used as 
a control.  After incubation, beads were recovered by gentle centrifugation and the 
supernatants were treated for a second round of depletion.  Resulting supernatants were 
then used in the specified experiments.   
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NUCLEOSOME SPACING ASSAY: The nucleosome spacing assay using micrococcal nuclease 
was carried out according to 153 with some modifications.  Briefly, demembranated sperm 
nuclei were incubated in egg extracts at 3,000 nuclei/µl.  After 90 min incubation in the 
presence of α32P-dATP, nuclei were isolated from extracts to obtain a total of 500 µg of 
labeled DNA.  Isolated nuclei were resuspended in 60 µl micrococcal nuclease (MNase) 
digestion buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM CaCl2).  MNase was 
added to a final concentation of 20 U/mg DNA and incubated at room temperature.  At the 
indicated times, reactions were stopped by the addition of 30 mM EDTA, 0.5% SDS and 
500 µg/ml proteinase K and incubation at 37ºC.  Samples were subsequently RNase treated 
and DNA extracted by phenol:chloroform and ethanol precipitation.  Samples were run on 
1.8% agarose gel in TBE.  
DNA REPLICATION ASSAY: DNA Replication Assays were performed by measuring the 
incorporation of α32P-dATP as described previously 137. 
PRODUCTION OF 35S-CHK1- 35S-labeled-Chk1 proteins were synthesized as previously 
described 139. 
OLIGONUCLEOTIDES AND LINEARIZED PLASMIDS: Annealed oligonucleotides poly(dG)70-
poly(dC)70 (termed pG-pC) were added to extracts at a final concentration of 50 µg/ml to 
induce checkpoint response as previously described 33.  Circular and linearized plasimds 
were prepared according to specification in 84 and added to extracts to a final concentration 
of 10 ng/µl. 
ISWI FLAG NUCLEAR PULL-DOWN: 25ng/µl of recombinant full-length wild type or 
mutant ISWI proteins (described above) were incubated in egg extracts for 90 min.  Nuclei 
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were isolated from these extracts and subsequently lysed by the addition of half the volume 
of the original extract in CHAPS buffer (10 mM HEPES-KOH, pH 7.5, 0.1% CHAPS, 
150mM NaCl, 2.5 mM EGTA, 20 mM β-glycerolphosphate, and 0.5% NP-40) and 
incubation at 4ºC with rotation.  Lysates were spun down in fixed rotor centrifuge for 10 
min at 14,000 rpm.  An equal volume of 20 mM HEPES-KOH (pH 7.5) was added to 
supernatant.  Four percent (4%) of total volume was collected and used as loading control 
(Input).  Diluted lysates were incubated with Flag-coupled Protein G magnetic beads and 
incubated for 60 min.  Beads were washed 4 times in CHAPS buffer and twice in HBS (10 
mM HEPES-KOH, 150mM NaCl) before addition of 2X-SDS sample buffer for SDS-Page 
and immunoblotting analysis. 
PROTEIN BINDING TO LINEARIZED PLASMIDS: Streptavidin-coated beads bound to linearized 
biotinylated plasmids were generated as described preiously 156.  Only one end of the single 
biotinylated plasmids (1X) will bind to the streptavidin beads and the unbound end will 
mimic DNA ends to which proteins involved in the response to DNA damage or repair will 
bind.  Double biotinylated plasmids (2X) mimic a closed circular DNA plasmid that does 
not elicit a DNA Damage Response (data not shown).  Beads were added to egg extracts at 
50 ng/µl and recovered through centrifugation.  Recovered beads were washed twice in 
CHAPS buffer and twice in HBS before addition of 2X-SDS sample buffer for SDS-Page 
and immunoblotting analysis. 
H1 KINASE ASSAY: Egg extracts (1 µl) were diluted into 100 µl EB (80 mM β-
glycerolphosphate, 20 mM EGTA, 15 mM MgCl2, and 1 mM DTT added fresh).  Diluted 
extracts (5.5 µl) were mixed with H1 kinase assay mix (14.5 µl) (2x H1 buffer: 40 mM 
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HEPES-NaOH, pH 7.3, 10 mM EGTA and 20 mM MgCl2, 5 mg/ml histone H1, 1 mM 
ATP, 1 mCi/100 µl γ32P-ATP) on ice.  The mixtures were incubated at room temperature 
for 15 min.  Reactions were stopped by adding 20 ml 2X SDS sample buffer and 5 min of 
boiling before being loaded onto SDS-Page gel. 
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RESULTS 
 
ISWI ASSOCIATES WITH ATR IN XENOPUS EGG EXTRACTS IN RESPONSE TO DNA DAMAGE  
In an effort to identify proteins that collaborate with ATR in the DNA Damage 
Response (DDR), an ATR pull-down was carried out in egg extracts containing damaged 
chromatin (Akiko Kumagai, Anna Shevchenko, and Andrej Shevchenko, unpublished 
data).  One of the isolated proteins was the Xenopus ortholog of the chromatin remodelling 
ATPase ISWI.  To investigate the regulation of this interaction within the context of the 
checkpoint activity of ATR, recombinant ISWI (HF-ISWI) purified from baculovirus 
infected Sf9 cells was added to egg extracts containing chromatin treated with different 
DNA damaging agents and subsequently recovered to determine the types of damage that 
stimulate this interaction (Figure 1A).  HF-ISWI isolated from nuclear lysates of extracts 
supplemented with undamaged sperm chromatin did not display any appreciable interaction 
with ATR.  Conversely, in the presence of chromatin that contains double-stranded DNA 
breaks (DSBs) generated by the restriction endonuclease EcoRI or in extracts where 
replication has been blocked by the DNA polymerase inhibitor aphidicolin (APH), the 
recovered HF-ISWI is found to associate with ATR.  Additionally, ATRIP and TopBP1, 
both of which bind to and are required for the activation of ATR in response to damage88,97 
also interact with HF-ISWI in the presence of damage.  The activation of ATR by TopBP1 
and ATRIP depends upon the ability of ATRIP to bind to Replication Protein A (RPA), 
which coats stretches of single-stranded DNA (ssDNA) that are exposed adjacent to breaks 
or when replication is blocked41,89,110.  Interestingly, binding of RPA to HF-ISWI was not 
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observed implying that the interactions with ATR, ATRIP and TopBP1 are not occurring 
on the RPA-ssDNA directly adjacent to sites of damage.   
 
 
 
 
Figure1: ISWI Interacts with ATR in a Manner that Depends on Damaged DNA and 
Phosphorylation 
 
(A) Nickel-purified recombinant FLAG and polyhistidine-tagged ISWI (HF-ISWI) was incubated in egg 
extracts (lanes 3–6 and 8–11) containing untreated sperm chromatin (lanes 3 and 8) or chromatin that was 
subjected to treatment with EcoRI  (lanes 4 and 9), aphidicolin (APH) (lanes 5 and 10) or caffeine (CAFF) 
(lanes 6 and 11).  FLAG beads were incubated with nuclear lysates from these extracts (lanes 2–6 are initial 
extract aliquots) and beads were reisolated and immunoblotted as indicated.  Lanes 2 and 7 contain no 
recombinant protein.  One microliter of CSF extract loaded onto lane 1 as a loading control. 
(B) ISWI recovered from nuclear lysates treated with EcoRI as described in (A).  Nuclear lysates used for 
samples in lanes 5 and 10 were supplemented with 50 µg/ml Ethidium Bromide (EtBr).  
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HF-ISWI also pulls down the origin specifying protein Orc2 even in the absence of 
damage, indicative of the strong association of ISWI with replicating chromatin153,154.  
Furthermore, supplementing egg extracts with caffeine to increase origin firing77,157 
similarly leads to the association between HF-ISWI and DDR factors in the absence of 
damage.  To assess the importance of chromatin in mediating the interactions between 
ISWI and components of the DDR pathway, nuclear lysates were supplemented with 
ethidium bromide (EtBr) to disrupt DNA structure (Figure 1B).  The addition of EtBr 
substantially diminished the capacity of HF-ISWI to interact with DDR proteins, as well as 
Orc2.  Taken together, these results indicate that ISWI interacts with ATR, ATRIP, and 
TopBP1 on DNA in response to DSBs and replication blocks. 
 
ISWI IS AN ATR SUBSTRATE 
In light of the damage-stimulated interaction between HF-ISWI and ATR, we 
sought to determine if ISWI is an ATR substrate.  In Xenopus egg extracts the exogenous 
addition of a TopBP1 fragment that interacts with the ATR-ATRIP complex, the ATR-
Activating Domain (AAD), triggers an increase in the kinase activity of ATR as evidenced 
by the increase in phosphorylation of the model substrate PHAS-I97 (Figure 2B, lane 7).  
Initially, a C-terminal fragment of ISWI corresponding to amino acids 694–1046 was used 
as a substrate.  As shown in Figure 2B, the ATR-ATRIP complex stimulated by the AAD 
of TopBP1 displayed good kinase activity towards ISWI(694–1046) (Figure 2B, lane 3).  
This phosphorylation event was not observed when the kinase complex was supplemented 
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with a mutant version of the TopBP1-AAD (W1138R) that fails to activate ATR (Figure 
2B, lanes 4 and 8).  
Xenopus ISWI contains three serine/threonine-glutamine (S/T-Q) consensus ATR 
sites (Figure 2A). To determine the specific ATR phosphorylation site on ISWI, small GST 
fragments of the regions containing the putative phosphorylation sites were expressed and 
purified from bacteria to be used as substrates in ATR kinase assays (Figure 2C).  The 
GST-ISWI(803–863) fragment was robustly phosphorylated in the presence of an active 
ATR complex whereas the GST-ISWI(692–752) was only marginally phosphorylated and 
GST-ISWI(473–533) was not phosphorylated at all.  To confirm the specificity of this 
phosphorylation, threonine 832 was mutated to a non-phosphorylatable alanine (T832A) 
and the resulting mutant fragment was incubated with the active ATR complex.  As shown 
in Figure 2D, ATR does not phosphorylate GST-ISWI(803–863-T832A).  The minimal 
phosphorylation of the GST-ISWI(692–752) is also compromised in the T721A mutant.  
ATM, which shares the same consensus phosphorylation sites as ATR, can also 
phosphorylate ISWI at T832 in vitro (data not shown).  In addition, full-length ISWI was 
only minimally phosphorylated in these kinase assays likely due to diminished accessibility 
of the kinase complex to the phosphorylation site in in vitro conditions (data not shown).   
 
 
 
Figure 2: ISWI is an ATR Substrate 
 
(A) Sequence alignment of human, fly and budding yeast regions around potential ATR phosphorylation sites 
in Xenopus ISWI along with their locations relative to conserved domains in the protein. 
(B) Recombinant ISWI C-terminus (H6-ISWI[694–1046]) was incubated with γ32P-ATP in the absence (lane 
1) or presence of protein eluted from a FLAG-ATRIP-Δ222 pull-down supplemented with either buffer (lane 
2), wild-type TopBP1 AAD (ATR Activation Domain GST-TopBP1[972–1279]) (WT) (lane 3), or W1138R 
mutant of the AAD that fails to activate ATR (lane 4).  Same conditions of lanes 1–4 used in lanes 5–8 with 
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PHAS-I as a substrate to confirm ATR activity.  Top panel is phosphorimage.  Lower panel is Coomassie 
Brilliant Blue stain to assess protein loading. 
(C) ISWI GST fragments containing potential phosphorylation sites were incubated with eluates from FLAG 
bead only pull-down (lanes 1,4,7 and 10), FLAG-ATRIP-Δ222 pull-down (lanes 2,5,8 and 11) or FLAG-
ATRIP-Δ222 pull-down supplemented with GST-TopBP1-AAD (lanes 3,6,9 and 12) and analyzed as 
described in (A). 
(D) ISWI GST fragments (lanes 1–3 and 7–9) and their corresponding non-phosphorylatable AQ mutants 
(lanes 4–6 and 10–12) were subjected to ATR kinase assays as described above.  PHAS-I used as a control for 
ATR activity (lanes 13–15). 
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PIKK-DEPENDENT INCREASE IN THE BINDING OF ISWI ONTO DSB-CONTAINING 
CHROMATIN 
ISWI binds to chromatin at the exit of mitosis and remains bound throughout DNA 
synthesis even in conditions when DNA replication is blocked154.  In agreement with these 
observations, we could consistently see a gradual increase in the chromatin binding of 
ISWI onto chromatin after CSF release to coincide with the timing of replication (Figure 
3A, see Figure 4D for typical replication kinetics).  Furthermore, inhibition of replication 
did not affect the chromatin binding of ISWI as evidenced by no detectable changes in 
chromatin accumulation in response to aphidicolin treatment (Figure 3B, lanes 4 and 5).  
On the other hand, the binding of ISWI onto chromatin slightly increased in the presence of 
double-stranded DNA breaks (DSBs) created by EcoRI (Figure 3, lane 6).  Because of the 
robust association of ISWI onto replicating chromatin this subtle increase in binding to 
EcoRI-treated sperm chromatin displayed a high degree of variability between experiments.  
Therefore, as an alternative method, we examined the binding of ISWI to bead-bound 
linearized plasmids incubated in egg extracts (Figure 3C).  In this experimental setup we 
could appreciate a rapid increase in the binding of ISWI onto single-biotinylated linearized 
plasmids (1x Biotin) that mimic DSBs.  The kinetics of binding to loose DNA ends was 
similar to those exhibited by other checkpoint response factors, mainly ATM.  Binding of 
ISWI onto plasmids with no loose ends (2x Biotin) progressively increased at later time 
points clearly illustrating the affinity of ISWI towards DNA in general and potentially 
explaining the observed variability of binding in experiments with sperm chromatin in egg 
extracts. 
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ATR phosphorylates ISWI on threonine 832, which lies at the boundary of a SANT 
domain, a conserved domain among chromatin remodeling proteins, which confers DNA 
and nucleosome binding properties (Figure 2A) (reviewed in 158).  We proceeded to gauge 
the importance of T832 in mediating the increased binding of ISWI onto chromatin with 
DSBs.  Initially, chemical inhibitors of ATM and ATR were used to determine if the 
activity of these kinases is responsible for the increased binding of ISWI onto DSB-
containing chromatin.  Inhibition of the checkpoint-stimulating activity of both ATM and 
ATR in the presence of caffeine abolished the DSB-stimulated increase of ISWI on 
chromatin (Figure 3B). Interestingly, treatment of caffeine alone in the absence of damage, 
which leads to an increase in origin density and origin firing77,157, resulted in an increase of 
chromatin-bound ISWI akin to the levels observed in the presence of EcoRI.  The increase 
in the amount of replicating chromatin in the presence of caffeine could concomitantly lead 
to an increased recruitment of ISWI onto chromatin.  The damage-independent increase 
caused by the addition of caffeine was not a consequence of PIKK inhibition, as treatment 
of extracts with wortmannin, which more strongly inhibits ATM, did not display this 
behavior.  In fact, treatment with wortmannin produced a decrease in the binding of ISWI 
onto chromatin independent of damage. 
To specifically determine the importance of T832 in mediating the binding of ISWI 
onto DSB-containing chromatin, we evaluated the chromatin binding of a mutant of HF-
ISWI with T832 mutated to alanine (HF-ISWI-AQ).  Endogenous ISWI strongly associates 
with chromatin and the binding of the recombinant HF-ISWI proteins onto chromatin was 
minimal.  To circumvent this limitation, we immunodepleted the endogenous ISWI from 
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egg extracts and looked at the binding of the recombinant proteins onto undamaged and 
EcoRI-treated chromatin in depleted extracts (Figure 3D). With the use of a polyclonal 
antibody generated towards the C-terminus of ISWI we could remove the vast majority of 
ISWI from egg extracts (Figure 3D, lane 3 and Figure 4A).  Wild-type HF-ISWI (HF-
ISWI-WT) bound effectively to undamaged chromatin and its association greatly increased 
in the presence of damage.  In this particular experiment, HF-ISWI-AQ bound normally 
onto undamaged chromatin whereas the increased binding onto EcoRI treated chromatin 
was not observed.  Taken together, these results indicate that the increase of ISWI binding 
onto DSB-containing chromatin is mediated by the activity of ATM and/or ATR. We are 
hesitant to draw any definitive conclusions about the role of the phosphorylation of ISWI 
on threonine 832 because we observed some variability in the binding of HF-ISWI-AQ 
onto damaged chromatin. 
 
 
Figure 3: PIKK-Dependent Increase in the Binding of ISWI onto DSB-Containing Chromatin 
 
(A) Chromatin fractions were isolated at indicated timepoints after release from CSF arrest.  A one-step 
chromatin isolation protocol was used in these experiments (see Experimental Procedures for details). Isolated 
chromatin fractions were subjected to SDS-PAGE and immunoblotted as indicated. 
(B) Chromatin fractions were isolated from extracts in the absence (lane 3) or presence of untreated sperm 
chromatin (lanes 4, 7 and 10) or chromatin that was subjected to treatment with aphidicolin (APH) (lanes 5, 8 
and 11) or EcoRI  (lanes 6,9 and 12).  Lanes 7–9 were treated with 5 mM caffeine (CAFF).  Lanes 10–12 
were treated with 100 µM wortmanin (WORT).  One microliter of M-phase extract (CSF) (lane 1) or 
Interphase (lane 2) as loading controls. 
(C) Right panel: Cartoon depicting single (1x biotin) or double (2x biotin) biotinylated linearized plasmids 
bound to streptavidin-coated beads.  See Experimental Procedures for bead preparation protocol.  Left panel: 
Bead-bound plasmids were incubated with interphase extracts.  At the indicated times, beads were reisolated 
and immunoblotted as indicated.  
(D) Extracts were treated with anti-ISWI antibodies (lanes 3 and 5–7) or control IgG (lanes 2 and 4) were 
subjected to two successive rounds of depletion.  Wild-type (WT-HF-ISWI) (lane 6) or T832A mutant (HF-
ISWI-AQ) (lane 7) were added back to depleted extracts.  Extracts were supplemented with undamaged (lanes 
8, 10, 12 and 14) and EcoRI treated (lanes 9, 11, 13 and 15) sperm chromatin.  After incubation, chromatin 
was reisolated and immunobloted as indicated. 
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DEPLETION OF ISWI COMPROMISES PROGRESSION THROUGH INTERPHASE   
Having established that ISWI associates with and is a substrate of ATR we 
proceeded to characterize the effects of the lack of ISWI on cell cycle progression in 
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Xenopus egg extracts.  As previously reported153,154, we could observe that the depletion of 
ISWI from egg extracts disrupted the spacing of nucleosomal arrays as evidenced by the 
loss of the periodic distribution of nucleosomes on chromatin incubated in ΔISWI extracts 
(Figure 4B).  Subsequently, we assayed the entry of these depleted extracts into mitosis by 
monitoring the phosphorylation of histone H1 (Figure 4C).  Undepleted extracts enter 
mitosis 150 minutes after release from MPF arrest whereas depleted extracts are slower, 
entering mitosis 60 minutes later, at 210 minutes post-release.  The same lag was observed 
when assaying the entry into mitosis by looking at the phosphorylation state of cyclin B2 
(data not shown). 
Work done in human cells by Varga-Weisz and colleagues has shown that a delay 
in cell cycle progression in the absence SNF2H, the human homolog of ISWI, was caused 
by reduced rates of nucleotide incorporation throughout S-phase159. These data suggest that 
the delay of entry into mitosis seen in ISWI-depleted extracts might be a consequence of a 
slowing of DNA replication.  Conversely, in the initial characterizations of Xenopus ISWI 
153, 154 noted that the absence of ISWI did not compromise the timely completion of DNA 
replication.  In our experiments we could reproducibly observe a reduction in the total 
amount of α32P-dATP incorporation in the absence of ISWI relative to mock depleted 
extracts (Figure 4D, n=3).  The nature of the discrepancy with previous work done in 
Xenopus remains unclear as other effects of the depletion are consistent with the previously 
published work.    
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Figure 4:  Multiple Effects of ISWI Depletion from Interphase Extracts 
(A) One microliter of extracts treated with control-IgG or anti-ISWI antibodies from two successive rounds of 
depletion.   
(B) Phosphorimage of nucleosome spacing assays from control-IgG- or ISWI-depleted extracts.   
(C) H1 kinase assays from control-IgG- or ISWI-depleted extracts.  Top and bottom panels labeled "Histone 
H1" are a Coomassie Brilliant Blue-stained gel to assess loading.  Middle panels labeled "Kinase Assay" 
reflect α32P-dATP incorporation. 
(D) DNA Replication from control-IgG- or ISWI-depleted extracts.  Bottom panel (graph) is a compilation of 
three separate experiments (n=3) of which the top panel is a representative example. 
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ASSESSMENT OF RESPONSES TO REPLICATION BLOCKS AND DSBS IN THE ABSENCE OF ISWI 
Depletion of ISWI causes defects that compromise the timely progression of 
extracts through interphase.  To further explore the defects that arise in ISWI-depleted 
extracts, we examined the activation of the checkpoint response to different types of DNA 
damage in the absence of ISWI.  Initially, the response to incompletely replicated DNA 
was analyzed by treating sperm chromatin with UV or by supplementing the extract with 
the polymerase inhibitor aphidicolin.  Both of these types of damage lead to the nuclear 
accumulation of the critical checkpoint response factor TopBP1 and DNA polymerase α, as 
well as the activation of the downstream effector kinase Chk1 (Figure 5B, lanes 2–4).  In 
the absence of ISWI, we could sometimes observe an amelioration of these responses in 
extracts treated with aphidicolin.  Conversely, no effect on checkpoint responses was 
observed when ISWI was depleted from extracts containing UV-treated chromatin.  We 
further examined the impact that the loss of ISWI has on checkpoint activation by looking 
at the chromatin binding of two key checkpoint response factors TopBP1 and Nbs1 in 
response to damage (Figure 5C).  Nbs1 is a component of the Mre11-Rad50-Nbs1 (MRN) 
complex, which is among the first responders to DSBs50,51,110.  Increasing doses of UV 
irradiation led to an increase in the binding of TopBP1 and Nbs1 onto chromatin with a 
maximal accumulation of these factors at 300 J/m2 (Figure 5C lanes 1-4).  Addition of 
aphidicolin to extracts led to an increase similar to what was optimally seen with UV 
irradiation (Figure 5C lane 5).  Similar to the defects seen in nuclear fractions, the absence 
of ISWI somewhat compromised the accumulation of TopBP1 and Nbs1 on chromatin in 
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response to aphidicolin (compare lanes 5 and 10), whereas both still accumulated normally 
on UV-treated chromatin.  
Next, we assesed the impact of the depletion of ISWI in the response to DSBs.  For 
this purpose we incubated annealed poly-dG poly dC oligos (pG-pC) in the extract, which 
selectively activate Chk2 and not Chk184.  Also, extracts containing linearized plasmids 
with different ends were added to extracts to activate the DSB response (Figure 5D).  In all 
cases, the absence of ISWI did not affect the phosphorylation of Chk2 in response to 
breaks.  Finally, we looked at the effect that the lack of ISWI might have on the response to 
PflMI-treated chromatin.  This restriction endonuclease triggers a more robust checkpoint 
response than EcoRI because the ends produced as a result of cleavage are not 
complementary.  Similar to the defects displayed above in response to aphidicolin, the lack 
of ISWI leads to a decrease of the nuclear accumulation of a wide range of checkpoint 
response factors, including TopBP1 and Nbs1, as well as a substantial reduction in the 
activation of Chk1 (Figure 5E).  These experiments were repeated multiple times in various 
iterations and the results displayed a high degree of variability.  This may be due to the 
efficiency of the depletion as a residual amount of the protein remained in nuclear 
fractions.  The differential depletion of other ISWI binding partners, which have been 
shown to be co-depleted with ISWI antibodies (153 and data not shown) could also 
contribute to the inconsistency.  Regardless of the variability, we venture to conclude that 
the absence of ISWI and ISWI-containing complexes partially compromises the ability of 
egg extracts to respond to specific types of DNA lesions. 
 
  
75 
 
 
Figure 5:  Effects of ISWI Depletion on the Response to Damaged DNA 
 
(A) One microliter of extracts treated with control IgG or anti-ISWI antibodies from two successive rounds of 
depletion.   
(B) Nuclear fractions from extracts treated with control IgG (lanes 2–4) or anti-ISWI antibodies (lanes 5–7) 
containing 35S-Chk1 and incubated with aphidicolin (APH) (lanes 3 and 6) or UV-damaged (lanes 4 and 7) 
sperm chromatin.  Lane 1 only contains one microliter 35S-Chk1 as a loading control. 
(C) Chromatin fractions from extracts treated with control-IgG (lanes 1–5) or anti-ISWI antibodies (lanes 6–
10) containing sperm chromatin subjected to increasing amounts UV-damage (lanes 1–4 and 6–9) or 
supplemented with aphidicolin (APH) (lanes 5 and 10) were immunobloted as indicated. 
(D) Extracts treated with control-IgG (lanes 1–6) or anti-ISWI antibodies (lanes 7–12) incubated in the 
absence of DNA (lanes 1 and 7) or supplemented with poly(dG)-poly(dC) annealed oligonucleotides (pG-pC) 
(lanes 2 and 8) or pBluescript (pBS).  pBS was either added uncut (lanes 3 and 9) or linearized with HindIII 
(lanes 4 and 10) to produce 5' overhangs, KpnI (lanes 5 and 11) to produce 3' overhangs or SmaI (lanes 6 and 
12) to produce blunt ends.  After incubation, one microliter of extracts was subjected to SDS-Page analysis 
and immunobloted as indicated. 
(E) Nuclear fractions from extracts treated with control IgG (lanes 2–3) or anti-ISWI antibodies (lanes 4–5) in 
the absence (lane 1) or presence of undamaged (lanes 2 and 4) or PflMI-treated (lanes 3 and 5) sperm 
chromatin were immunoblotted as indicated. 
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DISCUSSION 
 
The studies aimed at uncovering the structural determinants required to initiate the 
DNA Damage Response (DDR) have largely focused on establishing the length and type of 
DNA ends that are necessary to trigger the activation of ATM and ATR90,92,110,120,143,160.  
This work has demonstrated, mostly based on experiments done in vitro using synthetic 
oligonucleotides and linearized plasmids, that double-stranded ends, primed single-standed 
DNA (ssDNA), RPA-coated ssDNA and junctions between single- and double-stranded 
DNA are involved in mediating these responses.  Interestingly, in all cases the length of 
DNA adjacent to these structures is critical for optimal checkpoint function.  These results 
raise the possibility that in the physiological context of chromatin the area surrounding 
breaks and stalled forks must be cleared of obstructions, namely histones, to allow DDR 
components to recognize the checkpoint-inducing signatures and launch a response.  To 
examine this hypothesis, we have investigated the potential involvement of the chromatin 
remodeling ATPase ISWI in the DDR.  With this work, we have characterized novel 
interactions between ISWI and the critical DDR components ATR, ATRIP, and TopBP1 
on DNA in a damage-dependent manner.  
In a similar DNA-dependent manner, we can observe an interaction between ISWI 
and the origin specifying protein Orc2.   The interaction with Orc2 is consistent with the 
affinity of ISWI with replicating chromatin.  The involvement of ISWI in replication has 
also been observed in studies of the human ISWI isoform SNF2H (sucrose non-fermenting 
2 homolog).  The absence of a complex including SNF2H and Acf1 (ATP-utilizing 
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chromatin assembly and remodeling factor 1), which localizes to pericentromeric 
heterochromatin, interferes with late S-phase replication, an effect that can be reversed by 
"loosening" chromatin with DNA methylation inhibitors159.  Consistent with these 
observations, we see a decrease in the rate replication when ISWI is immunodepleted from 
egg extracts (Figure 4D).  Furthermore, the Williams syndrome transcription factor 
(WSTF), which together with SNF2H forms the WICH complex, is targeted to replicating 
foci by its interaction with DNA polymerase processivity clamp PCNA111.  The association 
of ISWI with active replication forks might also explain why in the presence of caffeine we 
notice an increase in the interaction of ISWI and DDR components in the absence of 
damage.  Caffeine inhibits a damage-independent function of ATM and ATR, which is 
required for regulating origin density and origin firing76,77.  Caffeine treatment also leads to 
an increase in the levels of ISWI on chromatin relative to untreated controls (Figure 3B, 
lane 7).  The abnormally high level of firing origins may lead to the eventual collapse of 
some forks leading to the generation of checkpoint-inducing structures.  This will in turn 
stimulate the recruitment of ATM and ATR to failed forks with no downstream 
consequences in checkpoint activation since the checkpoint-activating function of ATM 
and ATR is inhibited by caffeine.  The increase in abundance of both of these proteins in 
the vicinity of damage might explain the observed caffeine-stimulated interactions in the 
absence of induced damage. 
ATR preferentially binds to DNA that contains damage and this binding stimulates 
its kinase activity85.  The observed interaction between ISWI and ATR is occurring on 
damaged DNA, which should be enriched for active ATR molecules.  This prompted us to 
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explore the possibility of ISWI being a substrate of ATR.  Xenopus ISWI contains three 
potential ATR phosphorylation sites distributed throughout the protein.  The first potential 
site lies within a highly conserved nucleotide-binding region found in a wide variety of 
helicases and helicase-related proteins.  This site S499, conserved in all the observed ISWI 
homologs from yeast to humans, was not phosphorylated by ATR.  A second site, T721, 
lying in an otherwise uncharacterized region of the protein that displays a lower degree of 
conservation was marginally phosphorylated by ATR and ATM.  Finally, T832, which is 
highly conserved in eukaryotic ISWI homologs, was robustly phosphorylated by both 
ATM and ATR.  This site lies directly upstream of the SANT DNA-binding domain, which 
in conjunction with the adjacent SLIDE domain is required to mediate the substrate 
recognition and chromatin remodeling activities of ISWI161,162.  Mutation of this residue to 
a non-phosphorylatable alanine did not compromise the ability of ISWI to interact with 
ATR (data not shown).  Conversely, albeit with some level of uncertainty, it diminishes the 
binding of ISWI onto chromatin that contains DSBs.  The regulation of ISWI activity by 
post-translational modifications was recently observed by work done in Drosophila.  
Corona and colleagues observed the previously uncharacterized poly-ADP-ribosylation of 
ISWI by PARP. Poly-ADP-ribosylation inhibited the DNA and nucleosome binding 
abilities of ISWI as well as its ATPase activity in vitro163.  It is tempting to speculate that 
phosphorylation of T832 by ATR and/or ATM increases the affinity of the SANT/SLIDE 
region to broken DNA ends thereby retaining the already chromatin-bound ISWI onto sites 
of damage to mobilize nucleosomes in the vicinity of breaks.   
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To further investigate the potential for a functional involvement of ISWI in the 
DDR, we immunodepleted ISWI from egg extracts and monitored the activation of the 
checkpoint response.  The high affinity of ISWI to chromatin made it troublesome to fully 
immunodeplete it from egg extracts.  Even in these non-optimal depletions we could 
observe the effect of the absence of ISWI on the periodic spacing of nucleosomes.  
Additionally, we noticed a delay in the progression of ISWI-depleted extracts through 
interphase and into mitosis, accompanied by a reduction in the rate of replication as 
discussed above.   
The delay in mitotic entry in the absence of ISWI suggested an involvement in the 
regulation of cell cycle transitions and a likely role in checkpoint function.  Upon looking 
at the activation of the checkpoint response in the absence of ISWI, we noticed a reduction 
in the phosphorylation of Chk1 in response to aphidicolin.  The response to UV damage on 
the other hand was unaffected in the absence of ISWI.  Accordingly, the chromatin binding 
of TopBP1 and Nbs1 was reduced on ISWI-depleted chromatin exclusively in response to 
aphidicolin and not UV irradiation.  In fact, a slight increase in the levels of these factors on 
UV-treated chromatin was observed in the absence of ISWI.  The repair of UV adducts is 
largely resolved by the process of nucleotide excision repair (NER).  Upon recognition of 
damage, 24–32 nucleotides surrounding the damaged site are excised.  The incisions 
generated for this purpose have been shown to be stimulated in the presence of the ISWI 
containing ACF complex164.  It is conceivable to envision that the absence of ISWI would 
hinder the repair process of UV damage by NER and lead to a sustained checkpoint 
response as evidenced by the retention checkpoint factors on chromatin.   
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In the presence of DSB-containing chromatin, checkpoint activation is mildly 
compromised in the absence of ISWI.  As with aphidicolin treatment, Chk1 activation is 
reduced, as is the nuclear accumulation of TopBP1.  In response to DSBs, the activation of 
ATR in Xenopus egg extracts is mediated by the concerted activities of TopBP1 and Nbs1.  
Both of these, which are reduced on DSB-containing chromatin in the absence of ISWI, 
mediate the transition from the initial damage sensing by ATM to a subsequent ATR 
activation117,118.  Within this transition the activity of several partially redundant nucleases 
is required to resect the double-stranded end to generate the required ssDNA-RPA template 
for activation165.  In our view, ISWI might be instrumental in reconfiguring chromatin in 
the vicinity of the break by sliding histones away from the damage to allow the generation 
of the desired template with the appropriate length of vacant DNA for full checkpoint 
activation.  Moreover, the lack of an interaction between ISWI and RPA further suggests 
that ISWI is not functioning directly on the checkpoint-activating template but more likely 
in close proximity.  This might explain why the activation of the checkpoint was not fully 
abrogated in the absence of ISWI, hinting at the more likely involvement of ISWI in the 
amplification and persistence of the response.  The observed effects were somewhat 
variable, likely due to inefficient depletion of ISWI.  Also, other ISWI related factors might 
be involved in this process and to appreciate a full effect those might also have to be 
depleted. 
Taken together, these observations underlie the importance of chromatin structure 
in mediating the activation of the cellular response to DNA damage.  Our current work has 
been an effort to lay a foundation for future work, which will hopefully elucidate a better-
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defined mechanistic framework to understand the interplay between the activation of the 
checkpoint response and the changes in local and global chromatin configuration in 
response to damage. 
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CHAPTER IV 
 
CONCLUDING REMARKS 
 
The link between the cellular machinery that monitors the integrity of DNA and 
human pathologies associated with losing these critical functions has provoked a rapid 
expansion of knowledge on how cells respond to DNA damage.  Among the most critical 
advances, which have allowed a better conceptual comprehension of these responses, is 
having gained a better understanding of the interconnectedness that exists within the 
pathways that ensure genomic stability.  By now, it has been well established that the signal 
transduction cascades that operate in response to different types of lesions share a lot of the 
same components and can stimulate the activity of one another.  In addition, piercing 
observations as to how these responses are activated in the physiological context of 
chromatin are beginning to emerge.   
The traditional DNA Damage Response (DDR) paradigm suggested that the protein 
kinase ATR is activated by replication stress, and ATM, a related kinase, is activated in 
response to double-stranded DNA breaks (DSBs) in a parallel pathway23.  With our current 
work, detailed in Chapter II, we have gained a better mechanistic understanding of how 
ATR is activated in response to DSBs.  The activation of ATR in response to DSBs is 
achieved by the concerted activities of various proteins.  Initially, the MRN complex 
recruits and activates ATM on sites of damage48–54.  ATM then activates ATR by 
enhancing its interaction with a critical activator TopBP1117.  In addition, the activity of 
ATR is further stimulated by the interaction between TopBP1 and the MRN complex118.  
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Here we describe the role of an additional protein in this response, CtIP.  In our 
experiments, CtIP, which is recruited to DSBs to stimulate the processing of breaks to 
generate a proper template for repair by homologous recombination (HR), interacts with 
TopBP1 in a damage-stimulated manner57,112–114,120,125.  The interaction between CtIP and 
TopBP1 is mediated by the sensor MRN complex and by the phosphorylation of CtIP by 
either ATM or ATR, which share the same consensus phosphorylation site.  Furthermore, 
the stimulatory MRN/TopBP1 interaction, previously described by members of our 
laboratory, is partly compromised in the absence of CtIP.  Removal of CtIP from egg 
extracts also severely affects the activation of ATR in the presence of DSBs.  Taken 
together, our results more strongly implicate CtIP in the activation of ATR in response to 
DSBs by forming a large ATR-stimulating complex, minimally composed of CtIP, 
TopBP1, and the MRN complex.   
In Chapter III we have explored the role of the chromatin remodeling ATPase ISWI 
in DDR.  Herein we describe an interaction between ISWI, ATR, and two principal ATR 
activators ATRIP and TopBP1.  This interaction, which occurs on DNA, is dependent on 
the presence of damage.  In addition we characterize an ATR (and ATM) phosphorylation 
site on ISWI that is conserved among other metazoan ISWI homologs.  Furthermore, we 
gathered a number of observations to suggest that the chromatin remodeling activity of 
ISWI is, in some manner yet to be determined, involved in mediating the cellular response 
to DNA damage.  
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